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on the cover Structural biologist 
Thomas Steitz (left) shared the 2009 
Nobel Prize in Chemistry for his work 
in elucidating the structure of the 
large subunit of the ribosome.  
In December he accepted his award 
from His Majesty King Carl XVI 
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Tens of thousands of simultaneous experiments on 
gene function? It’s all in a day’s work at the Center for 
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Readers rate top docs, 
scientists, and teachers
Early last year, in anticipation of 
the School of Medicine’s bicen-
tennial in 2010, we asked for 
your thoughts on the most sig-
nificant events and personalities 
of the school’s first two centu-
ries [See “200 Years of Medicine 
at Yale,” Spring 2009]. 
Dozens of readers responded 
to our survey and offered their 
opinions, starting with who or 
what had the greatest impact 
in shaping the school. The 
winner hands down was the 
creation of the Yale system in 
the 1920s, which garnered the 
votes of 84.6 percent of our 
respondents. Runners-up were 
the school’s founding in 1810 
(10.8 percent) and the admis-
sion of women in 1916 (4.6 per-
cent). Several of you named the 
admission of African-Americans, 
the thesis requirement, and the 
involvement of students in pro-
viding health care to uninsured 
families in the New Haven com-
munity. One alumnus wrote, 
“The Yale system treats medical 
education like a serious field, 
not just a trade, and treats stu-
dents like serious adults who 
have something to contribute.” 
The greatest scientific 
advance? The finding by the late 
Dorothy Horstmann, m.d., 
fw ’43, the John Rodman Paul 
Professor Emerita of Epidemiol-
ogy and Pediatrics, that the 
polio virus enters the central 
nervous system through the 
bloodstream. That finding, 
which paved the way for the 
Salk vaccine, won the votes  
of 50.8 percent. John P. Peters’ 
transformation of clinical 
chemistry into a discipline of 
precise quantitative indicators 
of disease received 40.7 percent 
of the vote. And 8.5 percent 
chose the first antiviral drug, 
developed by William Prusoff, 
ph.d., in the 1950s.
In the clinical realm, 65.6 per-
cent said the first successful 
use of penicillin in the United 
States was the school’s greatest 
clinical advance. The discovery 
of nitrogen mustard as a treat-
ment for cancer won the votes 
of 23.4 percent; and 10.9 percent 
chose the introduction of fetal 
heart monitoring in the 1950s. 
Among faculty, 41.7 percent of 
you said John Fulton possessed 
the most extraordinary scientific 
mind; 35.4 percent chose Dorothy 
Horstmann; and 22.9 percent 
chose George Palade. 
Among basic science classes, 
you were most impressed with 
anatomy, although many of 
you also named physiology, 
pharmacology, and pathology. 
Your most memorable clinical 
experiences ranged widely—
from physical diagnosis to being 
a chief resident, from caring for 
victims of a 1950s New Haven 
fire to treating patients during 
World War II.
Your favorite extracurricular 
activities and favorite memories 
spanned the gamut from attend-
ing and participating in sports, 
plays, and musical productions to 
how to reach us
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or fewer) and 
news items to Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style, and content.
visit us on the web
yalemedicine.yale.edu
the meals you shared with class-
mates and colleagues; from trips 
to sanitariums to going to chapel; 
and from meeting and dating 
your future spouses to spending 
time in the outdoors. Many of 
you fondly remember New Haven 
pizza. And one of you wrote,  
“Do you really think we had time 
for extracurricular activities?”
—Charles Gershman
Yale Medicine receives 
award of excellence
In the fall of 2007 we asked 
freelance writer Jill Max to look 
into the status of the physical 
exam in medical education and 
practice. We’d been hearing 
physicians lament the decline of 
the physical exam as advanced 
technology appeared to be 
replacing their ability to glean 
insights into health by touch-
ing, feeling, and listening. Jill 
worked on the article for several 
months, interviewing attend-
ings, residents, medical students, 
and national experts on medical 
education. In January of this year 
we learned that the Association 
of American Medical College’s 
(aamc) Group on Institutional 
Advancement had honored her 
with a Robert G. Fenley Writing 
Award of Excellence for her arti-
cle, “The Lost Art of the Physical 
Exam” [Yale Medicine, Winter 
2009]. The award is the high-
est bestowed by the aamc to 
recognize outstanding writing. 
Congratulations, Jill.
3starting point
As the alumni reunion in June approached last year, our colleagues in the development and 
alumni offices noted that graduates of the School of Medicine had excelled not only in medi-
cine but in other pursuits. Many are outstanding clinicians and scientists, and many have 
gone on to serve as deans of medical schools. But they have also become venture capitalists, 
politicians, writers, soldiers, and entrepreneurs. To kick off what will become an occasional 
series in Yale Medicine, we include in this issue an article about medical school alumni who 
have sought to improve health not one patient at a time, but on a grand scale by pursuing 
changes in government policy. Over the years alumni have been involved in the creation of 
Medicare, launched anti-smoking campaigns, or worked as aides to politicians including 
Hillary Rodham Clinton and the late Edward M. Kennedy. In future issues we will explore 
other unusual career paths taken by med school graduates.
This series is also a response to what many of you asked for in our recent reader survey—
more news of alumni. We hope this series will help you keep in touch with classmates or perhaps 
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A Nobel for deciphering 
the ribosome’s subunit
Thomas Steitz is honored for solving 
the structure of a machine that makes 
proteins essential to life.
A few minutes before noon on October 7, 
Thomas A. Steitz, ph.d., Sterling 
Professor of Molecular Biophysics and 
Biochemistry and professor of chemis-
try, walked into the President’s Room 
at Woolsey Hall to sustained applause. 
Amid the cheering crowd were his col-
leagues on the Yale faculty, students and 
postdocs in his lab, the staff of his bio-
tech company, Rib-X Pharmaceuticals, 
and news reporters and photographers.
A few minutes later Yale President 
Richard C. Levin warmly greeted 
Steitz and his wife, Joan A. Steitz, 
ph.d., Sterling Professor of Molecular 
Biophysics and Biochemistry. Then 
Levin took his place at a lectern in front 
of a Yale-blue backdrop to say, “It is with 
the greatest pride and enthusiasm that I 
am here to introduce you to Tom Steitz, 
the winner of the 2009 Nobel Prize 
in Chemistry.” The news had arrived 
at 5:30 that morning in a phone call to 
Steitz from Stockholm.
Steitz, a Howard Hughes Medical 
Institute (hhmi) investigator, was one 
of three scientists recognized by the 
Royal Swedish Academy of Sciences for 
their work on the ribosome, a complex 
of rna and protein found in all cells. 
The Academy noted in its statement 
that this year’s chemistry prize honors 
“studies of one of life’s core processes: 
the ribosome’s translation of dna infor-
mation into life.” 
“It is an amazing piece of work,” 
Levin said. “It is fundamental, sweat-it-
out, figure-it-out science. It is like solv-
ing a gigantic jigsaw puzzle. This is the 
factory that makes the proteins that are 
the source of life.”
The other scientists honored were 
Venkatraman Ramakrishnan, ph.d., 
fw ’82, of the Medical Research Council 
(mrc) Laboratory of Molecular Biology 
in England, and Ada E. Yonath, ph.d., 
of the Weizmann Institute of Science 
in Israel. Ramakrishnan studied the 
smaller of the ribosome’s two subunits, 
while Yonath began making crystals 
of the ribosome in 1980, and Steitz 
concentrated on the ribosome’s larger 
subunit starting in 1995. Although the 
three teams tackled parallel problems 
related to the ribosome, Steitz said, they 
worked separately. “We communicated 
via papers and meetings.” 
chronicle news from cedar street
Structural biologist Thomas Steitz shared the 
2009 Nobel Prize for Chemistry in October for 
elucidating the structure of the large subunit of 
the ribosome, which helps translate dna infor-












• Thomas Steitz: Mapping the Ribosome
• Nobel lecture and awards ceremony
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was achieved, the next step was to 
beam X-rays through it to plot a dif-
fraction pattern that would reveal the 
ribosome’s atomic structure. In 2000 
Steitz and his team used a 2.5 billion 
electron volt X-ray beam at Brookhaven 
National Laboratory’s National 
Synchrotron Light Source. 
“It was the most exhilarating moment 
I have had in science, to peer into the 
inner workings of the ribosome and think 
about how it works,” Steitz said. “It was 
like trying to climb Mount Everest. We 
knew it was doable in principle but we 
didn’t know if we would ever get there.”
Although the prizewinning research 
began as a quest to find out how a com-
plex molecular structure works, it has 
since yielded clinical applications. By 
blocking ribosomal activity in bacteria, 
many antibiotics cure diseases caused 
by bacterial infection. No organism can 
live, Steitz said, “without a machine that 
makes proteins.” 
The company that Steitz co-founded 
in 2001, Rib-X Pharmaceuticals, has 
applied the insights obtained from 
the ribosome-antibiotic structures to 
develop new antibiotics that can be used 
to treat such multi-antibiotic resistant 
infections as mrsa. The company is 
developing both oral and intravenous 
drugs for treating skin infections, 
pneumonia, bronchitis, and soft tissue 
infections. One compound developed by 
the company has successfully completed 
phase 2 clinical trials. 
—John Curtis
et cetera • • •Steitz offered thanks for the sup-portive environment at Yale and in 
particular to Peter B. Moore, ph.d., 
Sterling Professor of Chemistry and 
professor of molecular biophysics and 
biochemistry, who worked with him 
on the ribosome project. “He has been 
a friend and colleague and co-worker 
and collaborator for many years. I very 
much appreciate his company and 
his work and his participation,” Steitz 
said. (Ramakrishnan was a postdoc-
toral fellow with Moore and Donald 
M. Engelman, ph.d., Eugene Higgins 
Professor of Molecular Biophysics and 
Biochemistry, from 1978 to 1982.)
The Steitzes came to Yale in 1970 
after three years as fellows at the mrc, 
where Francis Crick and James Watson 
had elucidated the double-helix struc-
ture of dna in 1953. As Levin noted, 
“Tom Steitz has a rare family. His wife 
Joan is one of the leading scientists at 
Yale as well. She is someone we hope 
will some day get the same recogni-
tion Tom received today.” (Their son, 
Jonathan G. Steitz, j.d. ’07, was drafted 
from Yale in 2001 by the Milwaukee 
Brewers as a right-handed pitcher, but 
tendonitis in his right shoulder ended 
his baseball career. He is now a consul-
tant in San Francisco.)
Since the late 1970s Steitz has been 
exploring how dna is copied into dna 
and then into rna at the molecular 
level and how rna makes proteins. 
In those early days, however, the 
National Institutes of Health offered 
little support for structural biology, he 
said. Then hhmi stepped in during the 
1980s. “hhmi funded five or six struc-
tural biology labs in the country. That 
helped the whole field because they set 
the agenda,” Steitz said.
By 1995 Steitz had turned to what 
Levin called “one of the most challeng-
ing and difficult problems in molecu-
lar science,” namely the structure of 
the ribosome’s large subunit. Steitz’s 
tool was X-ray crystallography, but in 
the early stages of the research, it was 
hard to form a high-quality crystal of 
the ribosome. Once a suitable crystal 
CO LLI N S N A M E D TO LE A D N I H
Francis S. Collins, m.d., ph.d. ’72, fw ’84, was 
appointed head of the National Institutes of 
Health (nih) in August, and in October was 
named one of nine recipients of the National 
Medal of Science. 
Collins is best known for leading the 
Human Genome Project and for his discover-
ies of disease genes. In June 2000 a draft of 
the human genome was announced and an 
initial analysis was published in 2001.
The National Medal of Science was cre-
ated in 1959 and is administered for the White 
House by the National Science Foundation. 
Awarded annually, the medal recognizes indi-
viduals who have made outstanding contribu-
tions to science and engineering. The medal, 
along with the Medal of Technology, is among 
the highest federal government honor given 
to scientists, engineers, and inventors. Collins 
and the other honorees received their awards 
from President Barack Obama at a White 
House ceremony in October.
—John Curtis
YA LE I N G LO BA L H E A LTH CO N S O R TI UM 
Yale has joined five universities and the 
Association of University Technology Managers 
(autm) to spur the dissemination of technol-
ogy and medicines to the developing world.
In a statement released in November, 
Harvard, Yale, Brown, Boston University, the 
University of Pennsylvania, Oregon Health & 
Science University, and autm said they will try 
to ensure that their intellectual property rights 
do not block access to drugs, vaccines, devices, 
and medical technologies in developing coun-
tries. They also agreed to try to develop licens-
ing strategies that promote global access to 
health technologies, to control patent rights so 
as to make lifesaving products available in the 
developing world, and to support the develop-
ment of health-related technologies aimed at 
diseases prevalent in the developing world.
“We believe the principles and strategies 
enunciated in this document will further our 
shared goal of providing access to the benefits 
of our medical inventions for the most needy 



























t o p  Annie Le, a promising graduate student 
in pharmacology and the child of Vietnamese 
immigrants, was murdered in a laboratory on the 
medical campus in September.
abov e  On September 14, the day after police 
found Annie Le’s body hidden inside a wall at 10 
Amistad Street, members of the Yale community 
gathered for a vigil at Cross Campus. 
chronicle news from cedar street
Yale mourns the loss of  
a gifted student and  
compassionate friend
Annie Le was a talented scientist, a car-
ing friend, a helpful lab mate, and a 
fashionista whose click-clacking high 
heels signaled her arrival from afar. Her 
friends, classmates, and teachers remem-
bered what her advisor called “Annie-
isms”—her fondness for fried chicken, 
her perfectly accessorized wardrobe, and 
her insistence on wearing a skirt even 
while doing messy lab experiments.
Scores of people touched by her full 
and all-too-short life gathered in Battell 
Chapel in October to honor Le, a 24-year-
old graduate student in pharmacology 
who had been killed in a Yale laboratory 
a month earlier. A laboratory technician 
had been charged with murder in the 
case and is being held on $3 million bail.
President Richard C. Levin described 
Le as “so emblematic of the kind of stu-
dent Yale wishes to educate and send out 
into the world, a model student for the 
Yale of the 21st century.” The child of 
Vietnamese immigrants, Le grew up in 
central California, was a standout high 
school student who garnered $160,000 
in college scholarships, won a prestigious 
nih fellowship while an undergraduate 
at the University of Rochester, and at 
Yale won a fellowship from the National 
Science Foundation. 
Working in the laboratory of Anton 
M. Bennett, ph.d., associate professor 
of pharmacology, Le studied how some 
fatty acids regulate an enzyme believed to 
be involved in cellular metabolism. She 
wanted to find out whether the enzyme 
is linked to metabolic disease. “She was 
happy with her life, happy with herself, 
and happy with her dreams,” Bennett 
said. “That’s why Annie was always smil-
ing.” Her work contributed to a research 
paper that will soon be published in the 
Journal of Clinical of Investigation and will 
be dedicated to her memory.
“Annie valued science precisely 
because she saw in it a moral purpose,” 
said Jon Butler, ph.d., dean of the 
Graduate School of Arts and Sciences. 
“She hoped that her research would stem 
the onset of metabolic disease.”
Friends also recalled Le’s lighter side. 
“I don’t know anyone else who could 
wear five-inch heels while doing labori-
ous mouse surgery, eat fried chicken 
and not gain an ounce, and use smiley 
faces in her presentations and not lose 
the respect of her audience,” said fellow 
graduate student Tara Bancroft. 
Le’s roommate reported her miss-
ing on the night of September 8. Five 
days later, the day she was to have been 
married to her college sweetheart, police 
found her body in a crawl space behind 
a wall in the basement of a building at 
10 Amistad Street, where Le had gone 
to check on her research mice. Police 
arrested Raymond Clark III, a lab tech-
nician who worked in the building, on 
September 17. Clark had not entered a 
plea at press time.
—John Curtis
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For the first time, dna 
sequencing leads to  
diagnosis and treatment
A Turkish boy suffering from dehy-
dration and failure to thrive became 
the first patient to receive an accurate 
diagnosis and successful treatment 
based on the complete sequencing of 
his protein-coding genes, thanks to the 
work of Yale researchers. 
A team led by Richard P. Lifton, m.d., 
ph.d., chair and Sterling Professor 
of Genetics and professor of internal 
medicine, used emerging genomics 
technologies to identify an unexpected 
and rare genetic mutation in the infant, 
who had previously defied diagnosis. 
That information allowed the baby’s 
doctors to embark on a successful treat-
ment program. 
The milestone achievement resulted 
from a new approach to dna sequenc-
ing known as whole-exome sequencing. 
This approach zooms in on the 1 to 2 
percent of the genome that carries pro-
tein coding information, where disease-
causing mutations are most likely to 
occur. Lifton and colleagues at the Yale 
Center for Genome Analysis—including 
Murim Choi, ph.d., a postdoctoral fel-
low, and Shrikant M. Mane, ph.d., direc-
tor of the genome analysis center at West 
Campus—worked out a method that 
combines gene chip technology to purify 
the target dna along with the latest 
high-throughput sequencing techniques 
to decode it. Their approach yields a 
comprehensive view of an individual’s 
protein-coding genes for a few thousand 
dollars—10 to 20 times less costly than 
sequencing the entire genome.
At the request of a Turkish doctor, 
the Yale group deployed the technol-
ogy to investigate the five-month-old 
baby, who was suspected of having a 
rare genetic kidney disease known as 
Bartter syndrome, marked by excessive 
urination. The baby’s dna arrived at 
Yale, and in just ten days, the research-
ers had their answer. The kidney gene 
was fine; however, the baby turned out 
to have an unsuspected mutation in a 
protein responsible for water and salt 
absorption in the intestines. That defect 
led to chronic chloride diarrhea, which 
in turn caused the child’s dehydration. 
Armed with that information, Lifton 
and colleagues then went back to other 
infants with similar symptoms attrib-
uted to Bartter syndrome, and identi-
fied five more with mutations in the 
intestinal transporter. 
The results, reported in the 
Proceedings of the National Academy of 
Sciences in October, show that the new 
technology can quickly generate clini-
cally useful results, bringing doctors 
and patients closer to the day when com-
prehensive sequencing information will 
be a routine part of medical care.  
“We believe this heralds the dawn 
of a new era in genetics and personal-
ized medicine,” said Lifton, who is also 
an investigator for the Howard Hughes 
Medical Institute. “As the cost of dna 
sequencing continues to plummet, it 
seems clear that this technology will be 
useful for clinical diagnosis in a num-
ber of settings.” 
—Pat McCaffrey
et cetera • • •
N E W STR ATEG Y FO R SWI N E F LU
A Yale researcher has proposed a swine flu 
vaccination strategy that would minimize 
cases and mortality and reduce costs. The 
strategy gives priority for vaccinations to 
those most likely to transmit swine flu rather 
than to those most vulnerable to the disease.
The Centers for Disease Control and 
Prevention and the Advisory Committee on 
Immunization Practices (acip) currently rec-
ommend targeting such high-risk groups as 
children under five; adults 65 or older; and 
pregnant women. In a paper published online 
in the August 20 issue of the journal Science, 
Alison P. Galvani, ph.d., associate professor 
of epidemiology (microbial diseases), and 
Jan Medlock, ph.d., an assistant professor of 
mathematical sciences at Clemson University, 
said that vaccinating schoolchildren and their 
parents would be more effective. 
acip’s vaccination policies, the study 
found, would result in 1.3 million infections, 
2,600 deaths, and $2.8 billion in economic 
impact. Galvani’s model, however, projected 
113,000 infections, 242 deaths, and a cost of 
$1.6 billion.
—J.C.
H OW H U N G E R B LO CK S F E R TI L IT Y
A molecule that may play a key role in obe-
sity, drug addiction, and depression also 
turns off the reproductive system in times  
of severe hunger, according to Yale scientists. 
In a report in September in the Proceedings 
of the National Academy of Sciences, the 
researchers identified the molecule as 
melanin-concentrating hormone (mch), a 
peptide that is made by the hypothalamus.
“Brain neurons that make mch are quiet 
most of the time, but when the body is in neg-
ative energy balance, mch neurons become 
active and can shut down brain neurons that 
control reproduction,” said Meenakshi Alreja, 
ph.d., senior author of the paper and associ-
ate professor of psychiatry and neurobiology.
—J.C.
Online: Yale Netcasts
Richard Lifton: Genes:  















Comparative Studies and the  
Politics of Modern Medical Care
edited by Theodore R. Marmor, 
ph.d., professor emeritus of public 
policy and political science at Yale; 
Richard Freeman, ph.d.; and Kieke 
G.H. Okma, ph.d. (Yale University 
Press) The editors of this volume 
have compiled essays covering 
health care policy debates and 
reforms in Canada, Germany, the 
Netherlands, the United Kingdom, 
and the United States. The book 
explores such issues as primary 
care, hospital care, long-term care, 
pharmaceutical policy, and private 
health insurance.
Handbook of Pediatric Chronic 
Pain: Current Science and  
Integrative Practice
by Brenda C. McClain, m.d., 
associate professor of anesthesiol-
ogy; and Santhanam Suresh, m.d. 
(Springer) The book addresses 
concerns unique to pediatric 
pain management, including the 
history of pediatric chronic pain; 
the advancement of pediatric 
pain management as a clinical 
subspecialty; the characteriza-
tion of common pain syndromes; 
and the assessment of specific 
pediatric and adolescent pain 
syndromes. It also discusses such 
interventional techniques as 
therapeutic blocks, implantable 
systems, physical therapy, and 
complementary therapies. 
Plastic Surgery: Indications and 
Practice
by John A. Persing, m.d., professor 
of surgery (plastic) and neurosur-
gery; Bahman Guyuron, m.d.; Elof 
Eriksson, m.d., ph.d.; Kevin C. 
Chung, m.d.; Joseph Disa, m.d.; 
Arun Gosain, m.d.; Brian M. 
Kinney, m.d.; and J. Peter Rubin, 
m.d. (Saunders) This two-volume 
reference work covers all aspects 
of aesthetic and reconstructive 
plastic surgery practice, with an 
emphasis on today’s techniques. 
The book’s content and format 
follow the core curriculum de-
signed by the academic chairs of 
plastic surgery, making it a practi-
cal resource for residents and an 
ideal review for the plastic surgery 
board examination. A bonus dvd 
is included with the book.
Transplant
by John A. Elefteriades, m.d. ’76, 
hs ’83, the William W.L. Glenn 
Professor of Surgery (cardiac) (Ro-
bot Binaries & Press) This medical 
thriller has cutting-edge technol-
ogy, seduction, and coercion as 
well as questions about the ethics 
of modern medicine.
Mother’s Milk
by Charles Atkins, m.d., lecturer 
in psychiatry (Severn House Pub-
lishers) A forensic psychiatrist 
tries to solve the mystery of two 
dead teenagers and a missing 
homeless schizophrenic while 
under pressure from her boss. 
Genetics and Medicine in Great 
Britain 1600 to 1939
by Alan R. Rushton, m.d., ph.d., 
hs ’80 (Trafford Publishing) This 
historical study examines the 
close professional relationship 
between British scientists study-
ing the nature of heredity and the 
practicing physicians of the day. 
It shows the close collaboration 
between scientists and physicians 
during the decades before World 
War II that has defined the pres-
ent understanding of the scope of 
modern “medical” genetics.
Anesthesiology Keywords Review
by Raj K. Modak, m.d., assistant 
professor of anesthesiology (Lip-
pincott Williams & Wilkins) This 
review book is based on the 
keyword list distributed to 
books & ideas
Every Patient Tells a Story: Medical 
Mysteries and the Art of Diagnosis
In her new book, Lisa Sanders examines the state  
of diagnostic skills.
The chances are good that you already know the work of 
Lisa Sanders, M.D. ’97, HS ’00, assistant clinical professor of 
medicine: she writes the monthly “Diagnosis” column in the 
New York Times Magazine. Or maybe you’ve seen House, the 
Emmy-winning, oddly addictive, not-quite-believable hospital 
melodrama for which Sanders is 
a consultant. Now Sanders has 
written a book that combines the 
medical sleuthing of “Diagnosis” 
and House with an examination 
of the state of diagnostic skills 
among contemporary physicians. 
The book also provides “insider” 
pleasures for those familiar with 
the School of Medicine or Yale-
New Haven Hospital: Many of 
the names of the physicians who 
unravel these medical myster-
ies are familiar, from Nancy 
Angoff to Majid Sadigh, from Eric 
Holmboe to Frank Bia.
With each story of a difficult 
diagnosis, Sanders expands 
on the issues that made it so. 
Recurrent chest pain and weakness in a young man. A heart 
attack? It turns out to be pernicious anemia. A woman with 
long-term weakness and joint pain. “Chronic” Lyme disease? 
No—polymyalgia rheumatica.
Sanders argues that physical examination is poorly taught, 
both in medical school and during residency. “See one, 
do one, teach one” doesn’t suffice for the complex skills of 
hands-on examination. 
She ends with a moving story of the search for the cause 
of her own sister’s death at 42.
—Cathy Shufro
Every Patient Tells a Story: 
Medical Mysteries and the 
Art of Diagnosis
by Lisa Sanders, m.d. ’97, 




residency program directors each 
year. Each entry begins with a 
keyword followed by a list of key 
points and a one- or two-page 
discussion. Entries cover all areas 
of anesthesiology.
Preoperative Medical Consulta-
tion, An Issue of Medical Clinics
by Lee A. Fleisher, m.d.; and Stan-
ley H. Rosenbaum, m.d., professor 
of anesthesiology, medicine, and 
surgery (trauma) (Saunders) This 
volume provides recommenda-
tions on ways to handle preopera-
tive consultation and preparation 
as well as perioperative man-
agement of surgical patients. It 
covers the following situations: 
emergency and urgent surgery; 
perioperative management of 
the ambulatory surgery patient; 
perioperative anticoagulation 
management; hematological 
problems in the preoperative 
patient; obesity, the metabolic 
syndrome, and the surgical 
patient; and noncardiac surgery in 
the patient with heart disease.
Pediatric Bioethics
by Geoffrey Miller, m.b.ch.b., 
professor of pediatrics (neurol-
ogy) and neurology (Cambridge 
University Press) This volume 
offers a theoretical and practi-
cal overview of the ethics of 
pediatric medicine. It serves as 
a handbook and resource for 
pediatricians, nurses, residents in 
training, graduate students, and 
practitioners of ethics and health 
care policy. Written by a team of 
experts, this book addresses the 
difficult ethical questions con-
cerning the clinical and academic 
practice of pediatrics.
DeVita, Hellman, and Rosen-
berg’s Cancer: Principles & 
Practice of Oncology, 8th ed.
by Vincent T. DeVita Jr., m.d., Amy 
and Joseph Perella Professor of 
Medicine and professor of epide-
miology; Theodore S. Lawrence, 
m.d., ph.d.; Steven A. Rosenberg, 
m.d., ph.d.; Ronald A. DePinho, 
m.d.; and Robert A. Weinberg, 
ph.d. (Lippincott Williams & 
Wilkins) The text provides infor-
mation on the science of oncology 
and multimodality treatments of 
every cancer type. To ensure a bal-
anced multidisciplinary approach, 
each major treatment chapter 
is co-authored by a surgeon, a 
medical oncologist, and a radia-
tion oncologist. Treatment of each 
cancer type is discussed by stage, 
with coordinated guidelines on the 
role of each treatment modality at 
each stage. Consideration is also 
given to cancer prevention, screen-
ing, palliative care, supportive on-
cology, and quality-of-life issues.
mif: Most Interesting Factor
by Richard Bucala, m.d., ph.d., 
professor of medicine (rheumatol-
ogy), pathology, and epidemiology 
(microbial diseases) (World Scien-
tific Publishing Company) This 
book describes the biology of the 
mif (migration inhibitory factor) 
gene. Human genetic studies have 
identified allelic forms of the mif 
gene, and high-expression alleles 
have been associated with rheu-
matoid arthritis, asthma severity, 
sarcoidosis, atopy, inflammatory 
bowel disease, and other inflam-
matory and infectious maladies. 
The book also discusses the role 
of the mif factor itself as a thera-
peutic target. 
The descriptions above are based 
on information from the publishers.
send notices of new books to
Cheryl Violante, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to cheryl.violante@yale.edu
on campus
SA R A LY N M A R K
Accounting for sex  
differences in medicine
The key to healing men often lies 
in studying women first, accord-
ing to a Yale expert who said that 
females respond differently not 
only to many diseases but also to 
therapies designed with males 
in mind.
“Go to the more challenging  
environment,” Saralyn Mark, m.d., 
associate professor (adjunct) 
of medicine and of obstetrics, 
gynecology, and reproductive 
sciences, urged at a talk in 
October sponsored by Women’s 
Health Research at Yale. “It’s 
kind of the reverse of what hap-
pened in the past, when men 
were the gold standard.”
Sexual differences in disease 
and therapy go beyond disparities 
in reproductive systems and size, 
said Mark. Most autoimmune 
diseases, for example, are more 
prevalent in females. Women 
may be more resistant to infec-
tion from swine flu but are harder 
hit when infected, especially 
while pregnant. Stem cells graft 
differently—female cells match 
best with female recipients, while 
male recipients of male cells fare 
the worst. Recognizing these dif-
ferences could improve develop-
ment of novel therapeutics.
“There have been significant 
advancements in the field of sex- 
and gender-based research, but 
it will require the development 
of public/private partnerships to 
translate research findings into 
improved clinical care for both 
men and women,” Mark said.
—J.D.
J O S H UA F R E E DM A N
When pizza and a starlet  
compete for attention
When both food and a sexy 
starlet appear in a television com-
mercial, pizza stirs up more brain 
activity, but increased stimulation 
from either doesn’t necessarily 
boost sales. 
Ads trigger a battle within 
the brain, said Joshua Freedman, 
m.d. ’88, associate clinical pro-
fessor at the ucla Jane & Terry 
Semel Institute for Neuroscience 
and Human Behavior. He con-
ducted fmri studies on subjects 
watching Pizza Hut commercials 
and found that shots of food 
“dominate” despite scenes of the 
scantily clad Jessica Simpson.
“Food tends to produce lots of 
activity in different parts of the 
brain,” Freedman told an audi-
ence at the Rudd Center for Food 
Policy and Obesity in October. 
The orbitofrontal portion of the 
prefrontal cortex typically associ-
ated with emotional connection 
may light up; however, the insula, 
which produces the sensation of 
disgust (perhaps at the idea that 
pizza is fattening), is also activat-
ed. “The battle is drawn, but it is 
unclear which region of the brain 
will win out,” Freedman said.
Advertisers know how to get 
attention, but there is bad atten-
tion as well as good, he said. “At 
the very least, if they saw these 
results they’d probably stop pay-

















A London surgeon and physician sought a Yale degree 
as part of his quest for upward mobility.
By Kerry Falvey
The colonies’ first medical degree
In 1723 Yale granted the first medical 
degree issued in the American colonies 
to Daniel Turner (1667–1741), a London 
surgeon-turned-physician who had nei-
ther attended Yale College nor even set 
foot in North America. Moreover, Yale 
would not have a medical school for 
nearly another century. 
The story has been extensively doc-
umented by Philip K. Wilson, ph.d., 
of the Penn State University College 
of Medicine, and much of this account 
is based on his work. It begins with a 
parcel of 25 books that Turner shipped 
across the Atlantic in September 1722 
as a gift to Yale. He was not the typi-
cal gentleman benefactor. In truth, 
Turner was not even a gentleman by 
the standards of 18th-century Britain. 
Born a tradesman’s son, Turner was a 
surgeon—an occupation then consid-
ered akin to manual labor. Medicine, 
known as “physic,” was the domain of 
university-educated gentlemen.
Turner had been admitted into the 
Barber-Surgeons Company in 1700 
after a seven-year apprenticeship. 
Seeking upward mobility, he expressed 
his ambition by becoming an author. 
Four of his case histories were pub-
lished in the Philosophical Transactions 
of the Royal Society of London—an 
unusual feat for a surgeon. He pro-
duced other works, including Apologia 
Chyrurgica: A Vindication of the Noble 
Art of Surgery. 
In 1711, Turner paid a fine of £50 to 
be released from the Barber–Surgeons’ 
Company and was licensed to prac-
tice physic by the Royal College of 
Physicians. Although he hoped to 
become a fellow of the Royal Society, 
Britain’s elite club of natural philoso-
phers, scientists, and physicians, Turner 
lacked the personal connections, social 
status, university education, or recogni-
tion as a scholar that might have gained 
him entry. Instead of buying a medical 
degree from a Scottish university—
a common practice at the time—he 
politely asked Yale to send him one.
In a letter written in Latin and 
addressed to the “Most Erudite Lords” 
of “Yale Academy,” Turner conveyed 
his desire to supplement the “infantile 
state” of Yale’s library by donating 25 
books from his personal collection. 
He saved his request for a postscript: 
“If Your Lordships judge me worthy 
of the Degree of Doctor of the Yale 
Academy, and care to transmit to me a 
Diploma, I shall accept it not only as a 
token of Your Gratitude, but shall con-
sider it an honor as great as if it had 
been conferred by another, even more 
renowned University.”
Despite the backhanded compliment, 
Yale awarded the honorary M.D. in absen-
tia in 1723. It remains unclear why the 
august members of the Yale Corporation 
bestowed the degree on Turner, although 
he had been recommended to them by 
Jeremiah Dummer, the Connecticut 
Colony’s agent in London.
Yale had been seeking donations of 
books for its nascent library since its 
early years, and most of those donations 
came through Dummer. By 1718 Yale’s 
library consisted of more than 1,300 
volumes, many donated by such leading 
intellects as Sir Isaac Newton. 
Turner’s efforts to have his honor-
ary degree recognized by the Royal 
College of Physicians were in vain. But 
he accepted the doctorate as a symbol of 
his erudition and medical knowledge, 
his recognition as an accomplished 
author, and his ability to contribute to 
an institution of learning. Thereafter, 
according to Wilson, he signed himself 
“Daniel Turner, M.D., of the College of 
Physicians in London.”
Yale was no diploma mill and Turner 
was no quack, yet the incident under-
scores how far medicine—especially 
medicine at Yale—has come in nearly 
300 years. What in the 18th century was 
a largely unscientific occupation has 
become a profession requiring rigor-
ous training and exacting standards for 
licensure. What was once the “Collegiate 
School” in Connecticut has become one 
of the world’s leaders in medical educa-
tion, patient care, and research.
This article has been excerpted and adapted from 
a forthcoming book by Kerry Falvey celebrating 
the bicentennial of the Yale School of Medicine 
(yalebooks.com/ysm200).
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abov e The letter sent by Daniel Turner in 
September 1722 seeking a medical degree. The 
letter was translated from Latin by C. Nockel 
Fabbri and first published in A History of Yale’s 
School of Medicine by Gerard N. Burrow.
lef t  A portrait of Daniel Turner by Johann 
Faber the Younger, 1734. This mezzotint depicts 
Turner as a learned scholar: all the trappings  
of gentility are apparent, including Turner’s 
lavish apparel, luxurious wig, and his extensive 
collection of books.
bel ow  Yale University owes its name to the 
donor of a collection of books for the fledgling 
school in 1701, and it has accepted such dona-
tions ever since. Turner’s offer of 25 books arrived 
in 1722, but the medical school library was not 
formalized until 1941 when three faculty members 






























P A I D
Burlington, VT 05401
Permit No. 696
Coming in October 2010
In its bicentennial year the Yale School of Medicine, 
one of the nation’s first medical schools, provides 
a useful lens through which to view two centuries 
of changes in American medicine and medical edu-
cation. A full-color, richly illustrated volume, to be 
published in October 2010, portrays the evolution 
of medicine in America by tracing the history of the 
sixth medical school in the nation, Yale School of 
Medicine, highlighting the signal events that have 
contributed to its development as a world-class cen-
ter for medical research, education, and patient care. 
Join our mailing list for advance ordering informa-
tion, prepublication discounts, and news about 




Mail  Bicentennial News, Office of Alumni Affairs,  
Yale School of Medicine, PO Box 7611,  
New Haven, CT 06519-0611
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c l o c k w i se from t o p :
Visitors entering from Park Street 
come in through an atrium that 
includes a player piano and a 
waterfall.
A detail from a mural in the atrium.
A rooftop garden on the seventh 
floor, which includes plantings and 
a stream, is designed as a medita-
tive space for patients.
A waiting room at Smilow lacks a 
television but features an aquarium 
with exotic fish. A television, the 
hospital’s planners believe, sends a 
message that patients are in for a 
long wait.
A detail from a mural in the atrium.
The hospital from Park Street.
Operating rooms were designed 
with all equipment hanging from 
the ceiling, making it easier for 
physicians, nurses, and technicians 
to move around and easier to clean. 
“What do I have to do to practice 
here?” ask new surgery recruits.
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The Smilow Cancer Hospital at  
Yale-New Haven is built around  
a new philosophy of patient care.
Ask to see the televisions in waiting rooms at the new Smilow 
Cancer Hospital at Yale-New Haven if you want to delight Abe 
Lopman, m.b.a., its executive director. He’ll smile triumphantly 
and proclaim that there aren’t any. “It always sends a mes-
sage that you’re going to be waiting for a while,” he explained. 
Other cancer centers have found tropical fish to be much more 
popular with patients, so several patient waiting areas in the 
new hospital feature saltwater tanks the size of loveseats. Exotic 
fish create serpentine ribbons of color—a markedly different 
sensory experience from those of Judge Judy or Rachael Ray as 
people wait to be called for an appointment.
“You feel cared for and nurtured here,” said Thomas J. 
Lynch Jr., m.d. ’86, director of Yale Cancer Center (ycc) and 
Smilow’s physician in chief. That feeling is engendered by 
everything from the artwork in the lobby to the trees and a 
stream in a rooftop garden. 
It’s a small thing, this preference for fish over televi-
sions. But it’s indicative of a larger principle: cancer care 
should focus on what the patient needs and wants. It should 
be personal. At 14 stories and 500,000 square feet, Yale-New 
Haven’s new cancer hospital cost an estimated $467 million. 
Every floor boasts an arsenal of leading-edge technology. Yet 
that simple core principle of patient care is the new facility’s 
true cornerstone. The ideal of personal cancer care shows in 
amenities intended to bring comfort to patients as well as 
in the building’s very structure, designed to change the way 
medicine is practiced.
By Colleen Shaddox















Bringing cancer teams together
Cancer care is by nature interdisciplinary; however, the physi-
cal distance between departments often made consultation a 
challenge. The traditional arrangement had physicians grouped 
by specialty, and patients traveled from the surgeon to the radi-
ologist to the oncologist and hoped that their medical charts 
arrived ahead of them. Clinicians recognized that they needed 
to work collaboratively but often resorted to faxes and e-mails to 
do so. “It’s always more difficult when the team members are 
not in one place and living and breathing these cases together,” 
said Edward Chu, m.d., professor of medicine (medical oncol-
ogy), and of pharmacology, and deputy director of ycc.
Now the patient will literally be at the center of care, with 
various disciplines housed together in suites that facilitate collab-
oration. The suites will be organized by the type of cancer treated 
there, and a multispecialty team is now mobilized to treat each 
patient. Before Smilow, cancer patients at Yale needed to visit as 
many as six different buildings to get their care, recalled Chu. It 
was inconvenient for patients—doubly so for the elderly or those 
exhausted from their treatments, he said. 
The new building is designed to foster collaboration 
in New Haven and beyond, said Robert Udelsman, m.d., 
m.b.a., chair and the William H. Carmalt Professor of 
Surgery. Teams will have access to conference rooms where 
they can look at diagnostic-quality images on large screens 
and interact with specialists at distant sites. Prognoses are 
more favorable for patients whose treatment is overseen by 
physicians with specific expertise and access to the best sci-
entific data, said Udelsman. 
Smilow is also designed to accommodate patients who 
must travel to get their cancer care at the medical center. 
Nearby 2 Howe Street, also constructed as part of the project, 
will feature residential units for patients and their families. 
“We want to be a destination hospital,” said Udelsman.
Waterfalls, fish, music, and coffee
The building had its grand opening on October 21, when donor 
Joel Smilow, a Yale College alumnus and the building’s name-
sake, and his wife, Joan, were honored. The first therapeutic 
radiology patient was seen a few days later. Other operations 
will be moving into the building in carefully choreographed 
stages through the spring. 
Patients typically enter for their first visit through 
the front door into a bright soaring space with a two-story 
Making cancer personal
waterfall, a café, a piano, and a large reception desk with staff 
who can look up a patient’s schedule for the day and offer 
directions. Patients can also enter through 55 Park Street, 
which is connected to the Air Rights Garage. The building has 
a walkway that leads directly to Smilow’s fourth floor. Yale-New 
Haven Hospital’s laboratories will be housed in 55 Park, con-
structed as part of the project.
Reserved parking is available by the front door for 
patients in therapeutic radiology who must visit daily during 
treatment. They’ll get treatment in the basement, but they will 
still enjoy the natural light that illuminates much of Smilow. A 
large skylight opening into the ground floor atrium brightens 
the reception area. Glass transoms above doors throughout the 
building add to the airy feel. Waiting areas have open spaces as 
well as private nooks to accommodate patient preferences. The 
cabinetry’s light wood tones create a less institutional look.
This décor is a change from the existing Hunter 
Radiation Therapy Center, said Peter M. Glazer, m.d. ’87, 
ph.d. ’87, hs ’91, department chair and the Robert E. Hunter 
Professor of Therapeutic Radiology. The ambiance of Hunter 
is not bad, Glazer said, but Smilow is a definite upgrade aes-
thetically and practically. “We have very good equipment now 
and will have even better equipment at Smilow,” he said. For 
example, a Novalis Brainlab system will be installed, allowing 
stereotactic treatment—minimally invasive techniques guided 
by a three-dimensional coordinate system—for tumors of the 
spine and other locations. The move also offers the therapeutic 
radiology staff housed there the benefits of being on a single 
floor. As the department doubles the number of exam rooms, 
Glazer expects better patient flow.
The ground floor is home to the Women’s Cancer Center 
for treatment of breast and gynecologic cancers. The center 
will also be the site of regular screening mammography. It is 
located across from a boutique selling wigs and other items for 
patients in treatment. The store will have a “Saks Fifth Avenue” 
feel to it, said Lopman.
New space for patients, more space for physicians
Smilow will increase imaging capacity for the Department of 
Diagnostic Radiology from five magnetic scanners to eight, 
including dedicated mri machines in the Breast Center and in 
the operating room for mri-guided surgery. Diagnostic radiol-
ogy, like many departments involved in Smilow, however, will 
not move all its faculty and staff to the new building. “The 
r i ght  Benefactor Joel Smilow.
far r i ght  Maria Menocal 
was the hospital’s first outpatient 
in October.
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logistics are challenging, but Smilow Cancer Hospital repre-
sents a wonderful growth opportunity for our department,” 
said department Chair James A. Brink, m.d. But he noted that 
the radiologists had been practicing at varied locations already. 
The improvements offered at Smilow and the additional capac-
ity in a department that sees more patients every year make the 
move “something we’re very excited about,” he said.
Smilow’s operating rooms are unusually large. All 
equipment is ceiling-mounted and slides into place wherever 
the surgical team wants it. This mobility includes drop-down 
high-definition screens that allow a surgeon to refer to an 
imaging study. The ceiling-based system makes it easier for 
the team to move and allows the room to be rapidly cleaned, 
explained Lopman. According to Udelsman, when physicians 
being recruited to the Department of Surgery tour the new 
facility, they ask: “What do I have to do to practice here?”
Children will continue to receive inpatient care at Yale-
New Haven Children’s Hospital. A connecting walkway will 
give them access to a pediatric floor in Smilow for treatment. 
For adults, the hospital offers inpatient rooms, all pri-
vate. And yes, these rooms have televisions. Private rooms are 
better for infection control and make it easier for nurses to 
practice, said Lopman. Clinicians will be able to enter informa-
tion on a bedside computer. The information will be available 
to every member of the team immediately. Each room has a 
sleeper sofa so that family members can stay overnight, and 
visiting hours never end at Smilow. “I’ve always been shocked 
by how we divorce the family from the patient at a time when 
they need their families more than anyone,” said Lynch.
On the rooftop garden, water features filter out the noise 
of the city and make the spot a destination for quiet walks. 
The building is equipped with high-speed elevators, but many 
stairwells have glass exterior walls to make them an inviting 
alternative. “We’re trying to encourage walking,” said Lopman. 
It’s an untraditional goal for a cancer center. But then Smilow 
doesn’t intend to be a traditional cancer center. “It’s built,” he 
said, “to change the patient’s experience.” YM
Colleen Shaddox is a freelance writer in Hamden, Conn.
A new hospital and a 
chance to make great 
strides against cancer
For Thomas J. Lynch Jr., m.d. ’86, 
director of Yale Cancer Center and 
physician-in-chief at Smilow Cancer 
Hospital at Yale-New Haven, the 
new building makes cancer personal 
on three levels. It provides “a warm 
and comfortable environment for 
patients.” The location of specialists 
in team suites allows for multidis-
ciplinary, patient-centered care. 
But the biggest innovation may be 
microscopic. Physicians will be able 
to do molecular profiling rapidly—a 
rarity even in the most sophisticated 
cancer centers. This technology will 
allow them to plan treatment suited 
to the genetic signature of each 
patient’s cancer. Combine that with 
information about a patient’s gener-
al health and history, and the result 
is personalized medicine—a treat-
ment plan for one specific patient.
These therapies hold the 
promise of greater effectiveness 
Thoracic Oncology Center. Lynch led 
teams that made discoveries in tar-
geted therapies in lung cancer and 
has published widely. He also main-
tained a clinical practice and hopes 
to continue doing so in New Haven.
He is one of the founders of the 
Boston-based Kenneth B. Schwartz 
Center and now serves as chair of its 
board of directors. Lynch pioneered 
the Schwartz Center Rounds, in 
which multidisciplinary teams dis-
cuss the social and emotional issues 
that arise in patient care. 
His plans for personalized medi-
cine at Yale are linked to the new 
West Campus research facility on 
the Orange-West Haven border. 
The complex, purchased from 
Bayer in 2007, gave the university 
400,000 square feet of research 
space that will include a cancer 
biology institute. “It’s Smilow and 
West Campus,” said Lynch. “You 
can’t do one without the other.”
Lynch foresees a rigorous 
program of research to match a 
growing list of specific genetic 
in killing cancer cells while reduc-
ing the side effects of treatment. 
Lynch’s enthusiasm for personal-
ized medicine springs from 25 years 
as an oncologist specializing in lung 
cancer and his dissatisfaction with 
the range of therapies available to 
his patients. He deems the past few 
decades’ advances in cancer treat-
ment only “modest.” The chance 
to make major strides against the 
disease through the combination 
of top-flight research and clinical 
programs is what drew the native 
Bostonian back to Yale.
Lynch returned to New Haven 
in April 2009 with the goal of mak-
ing Yale a leader in personalized 
medicine in both research and 
clinical care. Lynch formerly worked 
and taught at Harvard, where he 
was a professor of medicine and 
chief of hematology/oncology at 
Massachusetts General Hospital 
(mgh) Cancer Center. He also 
directed the Center for Thoracic 
Cancers at mgh and was director 
of medical oncology at the mgh 
signatures with treatments tai-
lored to be effective against them. 
This is the best hope, he believes, 
for improving outcomes in solid 
tumors, the cancers in which 
medicine currently has the least 
success. The marriage of Smilow 
and West Campus promises to take 
discoveries from the bench to the 
bedside more quickly. The hospital 
will have a team devoted to phase 1 
clinical trials so that patients get 
the most comprehensive support 
possible and so that data collection 
is enhanced. 
“If what we do in 25 years 
is practice the same oncology 
we’re practicing now, we haven’t 




Thomas Lynch: The Next Frontier 
in Cancer Treatment
Dean Robert Alpern was among 





























Scott Berkowitz took a year off 
from a cardiology fellowship at 
Johns Hopkins to work on the 
Senate Finance Committee under a 
training grant to investigate Medi-
care policy. “It’s been fascinating 
to see the political dynamics, and 
to realize that this is the center of 









Brenda M. Ritson, m.d. ’06, was only a few weeks into her fel-
lowship in Washington, d.c., in the early spring of 2005 when 
Sen. Hillary Rodham Clinton invited her into her office. 
“Come up with a progressive alternative to hard-cap tort 
reform,” the New York Democrat told her. “Here’s my Rolodex. 
You have three months.”
“I started sweating,” Ritson recalled. “I called my mom. 
And then I got down to business.”
Ritson was working in Clinton’s office as a fellow of the 
Women’s Research and Education Institute, an independent 
nonprofit organization, after her third year in medical school. 
After Clinton’s challenge, Ritson spent weeks educating her-
self at the Library of Congress and on the Internet. Eventually 
she chanced upon an article about a hospital in Michigan that 
had decided to apologize to patients who had been harmed 
by medical errors. By avoiding lawsuits the hospital was able 
to save millions of dollars, and used the money to hire more 
physicians and invest in innovative patient safety systems. 
Intrigued, Ritson met the hospital’s ceo and shaped the idea 
into a national proposal. Clinton, along with then-Sen. Barack 
Obama, introduced the idea as part of a bill in Congress in 
September 2005, calling it medic, for National Medical Error 
Disclosure and Compensation. Though the bill “died in com-
mittee,” Ritson said, the concept continues to pop up in new 
bills; a New England Journal of Medicine article; and the Sorry 
Works! Coalition, an advocacy group that urges full disclosure, 
apologies (when appropriate), and compensation (when neces-
sary) following adverse medical events. And the concept of 
apologizing for medical errors is catching on among hospitals, 
including Yale-New Haven Hospital, which began a similar 
program last year. “It makes me proud to know that my ideas 
By Jenny Blair
Some med school alumni effect change not one-on-one,  
but through health policy, and on a grand scale.
From Cedar Street 
to Capitol Hill
have somehow contributed to or influenced a discussion of a 
very challenging problem, and it excites me to watch the ideas 
grow and evolve,” says Ritson, now a practicing pediatrician.
Making a career in health policy
Ritson’s turn at working with lawmakers is something of a 
tradition among Yale physicians, many of whom have applied 
their medical training and experience to public policy. For some 
it is a sideline. But others hang up their stethoscopes and make 
policy a full-time career. A doctor’s journey into government 
often starts with an epiphany. One saw the light in the Amazon 
rain forest, another took up a challenge to go to Washington, 
and a third grew frustrated by the prevalence of preventable ail-
ments. But what they all have in common is an interest in help-
ing many people at once and a willingness to pursue their goals 
over years, if not decades. They often work behind the scenes, 
rarely getting credit for their achievements. Some work in gov-
ernment, others in advocacy groups, and some in academia. But 
all moved from treating people one on one to treating the public 
at large. They are among many alumni who choose careers 
beyond the clinic or the laboratory and find innovative and 
sometimes unusual ways to promote health.
William L. Kissick, m.d. ’57, m.p.h. ’59, dr.ph. ’61, 
developed an interest in public health during medical school 
while accompanying his wife, Priscilla, a nurse with the 
Visiting Nurse Association, on home visits. “There was a 
certain clash of cultures,” he said, recalling that her patients 
would often refuse to go to the hospital because they viewed 
it as a place to die. Later, as one of the first residents in a 
unique social medicine program at Montefiore Hospital in 















From Cedar Street to Capitol Hill
The policy makers
Scott A. Berkowitz, m.d. ’03, m.b.a. ’03
Fellow on the Senate Finance Committee
Larry C. Horowitz, m.d. ’69
Chief of staff and personal physician to the late Sen. Edward  
M. Kennedy
William L. Kissick, m.d. ’57, m.p.h. ’59, dr.ph. ’61
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Howard K. Koh, m.d. ’77, m.p.h.
Assistant secretary for health in the U.S. Department of Health  
and Human Services
Donald O. Lyman, m.d. ’68
Chief of California’s Division of Chronic Disease and Injury Control 
and architect of statewide anti-tobacco campaign
Brenda M. Ritson, m.d. ’06
Fellow in the office of then-Sen. Hillary Rodham Clinton and the 
Women’s Research and Education Institute, 2005
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medical system from the ground up. William H. Stewart, 
m.d., who would serve as surgeon general from 1965 to 1969, 
heard Kissick express his ambition at a public health confer-
ence in Detroit in 1963, and asked, “Why don’t you come to 
Washington and learn something first?” Kissick was soon 
assigned to the 11-person task force that developed Medicare. 
He spent seven years in Washington, contributing to some 13 
legislative efforts in health policy including Medicare, which 
became law in 1965.
Working with the underserved during medical school 
helped turn Larry C. Horowitz, m.d. ’69, toward policy-making, 
a career that later brought him national prominence as chief 
of staff and personal physician to the late Sen. Edward M. 
Kennedy, the Massachusetts Democrat. In medical school 
Horowitz was inspired by such mentors as then-Dean Fritz 
Redlich, m.d., and Yale’s charismatic President Kingman 
Brewster Jr. to join the Student Health Project, which assessed 
the health needs of the underserved populations in New Haven 
and New London, and migrant communities in Riverhead, 
Long Island. During Horowitz’s residency the Vietnam War 
nudged him into a two-year commitment to the public health 
sector as an alternative to the draft. He worked in Washington 
at the Health Services and Mental Health Administration, an 
umbrella organization that oversaw a number of national health 
programs. It was then that he caught the eye of Kennedy, whom 
he had invited to give a talk to his co-workers. Horowitz began 
that practice in Harkness Dormitory, inviting such luminaries 
as author William Styron and Walter and Eugene Rostow, broth-
ers who held posts in Democratic administrations in the 1960s. 
After joining Kennedy’s team Horowitz finished his residency 
while traveling between Palo Alto, Calif., and Washington as a 
Robert Wood Johnson fellow handling the Senate’s oversight of 
the pharmaceutical industry. He decided to continue in govern-
ment, he said, because he loved working on Capitol Hill. He 
served as Kennedy’s chief of staff from 1981 until 1986.
“It’s not like I decided, ‘That’s it for clinical medicine,’ ” 
said Horowitz, who is now a consultant to pharmaceutical com-
panies and runs an investment and entertainment company of 
his own. “It’s just that each step was so exciting and fulfilling 
and gave you a sense that you were contributing to something 
larger than yourself in a meaningful way. … Working for Sen. 
Kennedy was great fun. You had the opportunity to meet all 
the best minds that existed in the United States and elsewhere 
on the issues you cared about.”
A passion for prevention
Scott A. Berkowitz, m.d. ’03, m.b.a. ’03, is taking time off from 
a cardiology fellowship at Johns Hopkins to spend a year as a 
fellow on the Senate Finance Committee. His fellowship is part 
of an nih training grant in geriatrics investigating Medicare 
policy. “It’s been fascinating to see the political dynamics, 
and to realize that this is the center of the next generation of 
health care. To do whatever I can, however small, to help in 
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that process has been very rewarding,” he says of his front-row 
seat on health care reform. “There are definitely times when 
the physician background helps.” During the summer between 
his fourth and fifth years of graduate school, he too worked for 
Kennedy, and between his first and second years of internal 
medicine residency at Johns Hopkins, he worked in the office 
of former Illinois Gov. Rod Blagojevich.
Indeed, it is the big picture that pushes many doctors 
into policy. It happened to Donald O. Lyman, m.d. ’68, in the 
Brazilian Amazon, where he spent a summer as a medical 
student working with the Yale Arbovirus Research Unit. He 
arrived to find villagers waiting to see “the doctor.” Nervous 
at the prospect of treating rare tropical diseases, he nonethe-
less agreed to see them. The terrible banality of what he saw 
changed his career. “After about the 12th patient, I said to 
myself, ‘The things I am seeing are no-brainers. Malaria, mal-
nutrition, things like that. You can go into prevention and you 
could do a lot more good, both in places like this and at home, 
instead of treating people who are sick one-on-one.’ ” Before 
long, Lyman had signed on with the Epidemic Intelligence 
Service at the Centers for Disease Control. That led him to 
full-time public health work in California, where he is chief of 
the state’s Division of Chronic Disease and Injury Control and 
where he oversaw a statewide anti-tobacco campaign that is 
credited with saving tens of thousands of lives.
A passion for prevention also drives Howard K. Koh, 
m.d. ’77, m.p.h., who in June became the assistant secretary 
for health in the U.S. Department of Health and Human 
Services. In that position Koh serves as senior public health 
advisor to the secretary and oversees the Office of Public 
Health and Science, the Commissioned Corps of the U.S. 
Public Health Service, and the Office of the Surgeon General. 
(His brother, Harold H. Koh, j.d., former dean of the Yale 
Law School, is legal advisor to the U.S. Department of State.) 
“I’ve seen too many patients suffer preventable suffering 
and die preventable deaths. The only answer to that chal-
lenge is promoting prevention through public health.” After 
finishing residency, Koh taught cancer prevention and got 
his first taste of satisfying policy work in 1992 while head-
ing a coalition that successfully advocated a tobacco tax in 
Massachusetts. Later, as that state’s public health commis-
sioner, he guided his state from 10th- to third-healthiest in 
the nation, in part because of a high quitting rate among 
smokers. Like Horowitz and Kissick, Koh also honed an inter-
est in the needy while at Yale. Though he said his parents 
impressed upon their children the importance of both educa-
tion and service to others, he names the Reverend William 
Sloane Coffin Jr., the civil rights leader and Yale chaplain 
between 1958 and 1975, as a strong influence. “He always 
preached about the broader perspective on life and serving 
Brenda Ritson spent a year in the 
office of then-Sen. Hillary Rodham 
Clinton, developing a progressive 
alternative to tort reform. 
Ritson is now a pediatrician in a 
practice in Connecticut. She plans 






















undergraduates about the evolution of American health care 
policy. He is decidedly skeptical about current health care pro-
posals. “I’ve been in the racket for a half-century,” he said, “and 
I’ve learned just about everything that won’t work.”
Despite those years spent crafting and teaching policy, 
Kissick’s heart has always remained in medicine. His last 
clinical experience was in 1963, when he was called to a home 
delivery at 3 a.m. during a snowstorm. But his identity as a phy-
sician is tenacious. Although a great many lawyers who pass 
the bar never practice law, said Kissick, “when you go to medi-
cal school, you’re hooked. You can’t get out.”
Berkowitz, who plans to pursue clinical cardiology along-
side a policy career, believes that medicine opens more doors 
to more career paths than it did in the past. “I think it’s really 
important for people going in and starting medical school to 
recognize that the opportunities with a medical degree, both 
in terms of taking care of patients and impacting policy on a 
broader level, are really great and really exciting,” he said.
Koh, who is board-certified in four specialties, practiced 
clinical medicine for more than 30 years until his Washington 
post began. But he is thrilled to be on the front lines of policy, 
and relishes the interdisciplinary nature of his job. “I really 
enjoy it when the worlds of medicine and law and business and 
community and advocacy all interconnect in the form of public 
health,” he said. 
Ritson is building up clinical pediatric experience and 
plans to return to Washington within a few years. Miller did 
volunteer clinical work but spent the bulk of his time outside 
the hospital. After working with the nih on hiv/aids policy, 
he joined the team of Rep. Sander M. Levin of Michigan, where 
he worked on Medicare a generation after Kissick. He also 
worked with then-First Lady Hillary Rodham Clinton’s health 
care task force in its first incarnation in the 1990s. Miller now 
blogs and runs a consulting company. And Horowitz, though 
he later played a prominent role in Sen. Kennedy’s health 
care plan, remembers that he “looked up one day and I hadn’t 
practiced in many, many years.” He hadn’t made a conscious 
decision about it, he said. “My interests had changed. What I 
wanted to do in life had evolved.”
Lyman cautions that giving up one’s patients and the 
one-on-one relationship is not for everyone. “There is never a 
person—not a soul—that will ever see me on the street and 
say, ‘Oh, thank you that I never got lung cancer!’ You have to 
have that same satisfaction from looking at a graph with a line 
going down.”
After decades in government, Lyman has seen governors 
and legislators come and go while he and his team maintain 
stability behind the scenes. That continuity, the ability to con-
tinue to contribute, is part of the satisfaction. “You don’t see us; 
we are very quiet. We can’t stick our heads out very far. But we 
are the ones who stay.” YM
Jenny Blair, m.d. ’04, is a writer and physician in New Haven.
the underserved—caring for those in society who are counted 
least and put last,” said Koh of Coffin Jr., who died in 2006. 
“I think of him often and miss him tremendously.”
How to make policy work
“Fresh-faced shiny kids” in their late 20s and early 30s—which 
might describe the speaker herself—are the people doing 
much of the work in Washington, d.c., said Ritson. Many 
arrive with little or no experience in the jobs they’re about 
to undertake. No one taught Ritson how to research a policy 
proposal; she was expected to figure it out herself. The system 
seeks the self-motivated and the adaptable.
For example, after a surgical internship and a lab research 
year, Michael D. Miller, m.d. ’86, wound up dissecting the 
federal budget. Seeking to work in health care at the “ultimate 
macro level” after leaving an orthopaedics residency, he entered 
the policy arena as a fellow with the American Association 
for the Advancement of Science (aaas). He worked on fund-
ing for biomedical research at the Office of Management and 
Budget—a plum location where no aaas fellows had landed 
before. There, he says, he got a bird’s-eye view of the entire fed-
eral government by studying the flow of funds. “It’s crucial to 
understand how money flows,” he said. “I was—and still am—
astounded by the number of people at senior levels who don’t 
understand the budget process.”
The relationship between money and policy is complex 
and not always healthy. Policy, Lyman believes, should drive 
funding. “You start with the policy; you start with the social 
justice, and the dollars follow.” But sometimes money appears 
to lead. “There were a number of legislative hearings when the 
advocates thought they had the votes,” Lyman said. “In comes 
the Assembly speaker and he walks around the room and he 
talks to each and every member of the legislative committee 
individually, and they either turn red with rage or they walk 
out. Then they vote down the bill. The advocates lament that 
they could just hear tobacco money passing hands.”
For Lyman, the words he uses are as important as 
money. He credits the Hollywood advertising industry for the 
success of the phrase “secondhand smoke” during his anti-
tobacco campaign. And he is careful to make his public health 
messages culturally appropriate. But the fading prominence of 
the phrase “social justice,” a concept that underlies everything 
he does, saddens him.
“It is just astounding that the vocabulary, the metaphors, 
the mindset are very geared to money,” he said. “What hap-
pened to social justice? What happened to the quality of care? 
What happened to outcomes?”
Keeping a hand in medicine
In 1969, Kissick left Washington for the Wharton School of 
the University of Pennsylvania, where he taught for decades 
and helped found several combined-degree programs. He is 
now adjunct professor of political science at Yale, and teaches 
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Howard Koh served as public health 
commissioner in Massachusetts and 
is now assistant secretary for health 
in the Department of Health and 






















A campaign by Yale alumni has amplified  
doctors’ voices in the health care debate.
In 2007, when Vivek Murthy, m.d., ’03, m.b.a. ’03, an 
internist at Brigham and Women’s Hospital in Boston, was 
working on then-candidate Barack Obama’s New England 
steering committee, he noted how few physicians were 
involved. “It was especially striking since health reform 
was part of the campaign,” he said. When Obama won the 
Democratic Party nomination, Murthy and fellow physicians 
founded the national group Doctors for Obama.
After the election, the group changed its name to 
Doctors for America (dfa) and its focus. With a private grant 
sponsored by the Center for American Progress, dfa pro-
motes health care reform and encourages physicians to speak 
out on the process.
“It’s never been more important for doctors to be 
engaged,” said Mandy Krauthamer Cohen, m.d. ’05, m.p.h., 
the group’s executive director.
More than 15,000 physicians have signed on in sup-
port of legislation that brings affordable insurance to all 
American families, ensures high-quality care, expands access 
to care, and creates practice environments that allow physi-
cians to focus on patient care. dfa also encourages physicians 
to share their stories and their ideas for change.
“Real stories speak clearly across the spectrum,” said 
Murthy, president of the group. dfa leaders shared hundreds of 
online comments and stories at a physician stakeholders’ meet-
ing sponsored by the White House Office of Health Reform in 
June. In October, dfa physicians were among doctors from all 
50 states invited by President Obama to a Rose Garden address, 
where the physicians shared their stories with the press.
Comments have focused on certain themes, Cohen  
said: primary care is undervalued and under-reimbursed; 
the health care system focuses on sick patients rather than 
on prevention and wellness; reimbursements should reflect 
time spent with patients, rather than the number of proce-
dures completed; and the need for malpractice reform. And 
90 percent of the dfa respondents supported a public option 
to provide health insurance for the uninsured.
Following are responses from physicians affiliated with 
the School of Medicine, including students, alumni, residents, 
and faculty. YM
Q
“In the current system, what  
frustrates me the most is ...”
“I want health reform that ...”
Since April 2009, dfa 
has been collecting the 
responses of physicians  
and medical students 
around the country to  
two questions:
The goal is to share  
physicians’ perspectives 
with legislators as they 
create a health care bill.  
(voicesofphysicians.org)
We’d like to hear your 
thoughts on health care 
reform. Please send us your 
ideas at ymm@yale.edu.
By Kohar Jones, m.d. ’05
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What frustrates me the most is 
that patients need to pay a co-
pay for appointments, including 
screening colonoscopy, which 
can be as high as $500; the high 
cost of prescription medication; 
and the lack of a reasonable, 
user-friendly electronic medical 
record (emr).
I want health reform that 
offers all patients a choice of 
physician care and prescription 
coverage; offers and encour-
ages preventive medical care; 
and brings together the many 
very intelligent computer pro-
grammers in this country in a 
Manhattan Project-style effort to 
solve the problem of the emr.
Deborah D. Proctor, m.d.
Professor of Medicine  
(Digestive Diseases)
Yale School of Medicine
What frustrates me most is ...  
(I can’t pick just one): gross 
inequality in access to health 
care; the [mistaken] idea that 
all Americans have access to 
health care (“After all, you just 
go to an emergency room,” as 
former President George W. Bush 
famously stated); the de facto 
rationing that occurs among 
the insured and underinsured so 
insurance companies can main-
tain steep profits; “cost-cutting 
measures” that are not based 
on sound biomedical evidence; 
defensive medicine fueled by 
unchecked litigation; the com-
plete lack of attention to preven-
tive health care; and the fact that 
a primary care doctor working her 
tail off to provide quality, cost-
saving care earns the smallest 
salary in medicine.
I want health reform that 
doesn’t placate big pharma and the 
insurance industry, that is single-
payer, universal, equitable, and 
focuses on health over health care.
Michael Herce, m.d. ’05, m.p.h.
Staff Physician, Abwenzi Pa Za  
Umoyo/Partners in Health, Malawi
Hospitalist, Brigham & Women’s 
Hospital, Boston
Instructor in Medicine, Harvard 
Medical School, Boston
In the current system, what 
frustrates me most is that we 
spend more than any country in 
the world on health care and still 
have embarrassingly poor popu-
lation health indicators.
I want health reform that 
invests in primary care to build 
a health system that focuses on 
prevention and population health.
Mandy Krauthamer Cohen, m.d. ’05, 
m.p.h.
Executive Director, Doctors for America
Washington, D.C.
I want health reform that provides 
preventive and comprehensive 
services, including mental health, 
to everyone in the country, with 
limited bureaucracy. I also want 
reform that solicits the input of 
patients and physicians about 
what should be covered and how 
much reimbursement should be.
Carla Marienfeld, m.d.
Department of Psychiatry
Yale School of Medicine
In the current system, what 
frustrates me the most is the 
system design that interferes 
with the doctor-patient rela-
tionship and places physicians’ 
administrative responsibilities 
as a greater obligation than 
time spent with patients. 
I want health reform that pri-
oritizes patients and streamlines 
the paperwork done by doctors 
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In the current system, what 
frustrates me the most is that pri-
mary care medicine has become 
untenable for so many physicians; 
the lack of universal access to pri-
mary care; and all the wasteful-
ness in our current system.
I want health reform that pro-
vides outstanding and accessible 
primary care and specialty care 
to all Americans. I want health 
reform that makes the practice of 
primary care medicine appealing, 
manageable, and meaningful. I 
want health reform that elimi-
nates the wastefulness in our cur-
rent medical system.
Anna B. Reisman, m.d.
Associate Professor of Medicine
Yale School of Medicine
In the current system, what frus-
trates me most is the crushing 
cost of medical care at the end 
of life. A significant number of 
Americans die in the intensive 
care unit, often after overly 
aggressive procedures and 
management.
I want health reform that 
provides evidence-based guide-
lines that strictly define futile 
medical care.
Curtis Weiss, m.d. ’05 
Pulmonary/Critical Care Fellow,
Northwestern Memorial Hospital, 
Chicago, Ill.
In the current system, what frus-
trates me the most is that health 
care is a privilege, not a right.
I want health reform that pro-
vides care for everyone.
Auguste H. Fortin VI, m.d., m.p.h.
Associate Professor of Medicine




Two faculty get 
“genius” grants
mary e. tinetti, m.d., the 
Gladys Phillips Crofoot Professor  
of Medicine and professor of  
epidemiology and of investigative 
medicine, and Richard O. Prum, 
ph.d., the William Robertson 
Coe Professor of Ornithology, 
Ecology, and Evolutionary Bio-
logy, will each receive a five-year, 
$500,000 “genius” grant from  
the MacArthur Foundation.
Tinetti, director of the Yale 
Program on Aging, has devoted 
much of her research to fall pre-
vention for the elderly. She was 
the first investigator to show that 
older adults at risk for falling and 
injury could be identified, that falls 
and injuries are associated with a 
range of serious adverse outcomes, 
and that multifaceted risk-reduction 
strategies are both effective and 
cost-effective. She is working to 
translate these findings into clinical 
and public health practice.
Tinetti has also investigated and 
published extensively on functional 
disability and mobility impairment. 
Her most recent research focus is 
on clinical decision making in the 
face of multiple health conditions, 
particularly trade-offs among 
health conditions; the harms and 
benefits of commonly recom-
mended treatments; and the need 
for universal health outcomes that 
transcend individual diseases.
Prum, chair of the Department of 
Ecology and Evolutionary Biology 
and curator of ornithology at the 
Yale Peabody Museum of Natural 
History, has diverse research inter-
ests that cross many academic 
boundaries. He is best known for 
his studies of the development 
and evolution of feathers and for 
research that supports the theory 
that dinosaurs were ancestors of 
contemporary birds.
A cardiologist’s last  
lesson in heart sounds
lawrence s. cohen, m.d., hs ’65, 
taught his last class on September 15 
in “Learning Heart Sounds,” a 
module he has taught for 39 years. 
“When I got here 30 years ago, 
Larry was known in the community  
as the King of Hearts,” said Margaret  
J. Bia, m.d., professor of medicine 
and director of the Clinical Skills 
Training Program, who was present 
at the class. She then presented a  
gift to Cohen—a singing teddy bear  
inscribed with the words “Larry 
Cohen, m.d., King of Hearts.”
Cohen, the Ebenezer K. Hunt 
Professor of Medicine, led the 
early Yale trials of thrombolytics—
clot-busting medications used to 
combat coronary disease, strokes, 
and heart attacks. Since the mid-
1970s, Cohen has overseen some 
two dozen trials of heart disease 
treatments. His expertise is in 
cardiology, but members of the 
medical community have long 
sought Cohen’s advice on a range 
of topics. 
In 1991, then-Dean Leon E. 
Rosenberg, m.d., hs ’63, asked 
Cohen to serve as deputy dean, 
a role he continued to fill under 
deans Robert M. Donaldson Jr., 
m.d., and Gerard N. Burrow, 
m.d. ’58, hs ’66. Cohen has also 
been a special advisor to three 
deans, including current Dean 
Robert J. Alpern, m.d., Ensign 
Professor of Medicine. 
Beginning in 1996, Cohen 
worked with the school’s ombud-
sperson, Merle Waxman, m.a., to 
train more than 1,000 postdoctoral 
fellows, graduate students, and 
faculty in ethical issues related to 
the conduct of research.
Cohen continues to serve as a 
faculty member and practicing car-
diologist. He will remain a member 
of the admissions and progress 
committees and will continue in 
mentorship roles. 
Daniel L. Jacoby, m.d. ’00, assis-
tant professor of medicine (cardiol-
ogy), succeeds Cohen as instructor 
of “Learning Heart Sounds.” “It is 
remarkable that Larry Cohen has 
left such an imprint. He comports, 
with his composure and his way of 
communicating, the most profes-
sional demeanor you could possibly 
have as a physician,” said Jacoby, 
who attended “Learning Heart 
Sounds” as a medical student at 
Yale in the 1990s.
Ronald A. Adelman, m.d., m.p.h., 
associate professor of ophthal-
mology and visual science, was 
proclaimed a Knight of the Blind 
in June by the Connecticut Lions 
Eye Research Foundation. This is 
the foundation’s highest award 
bestowed at the state level. It was 
presented in recognition of Adel-
man’s work in ophthalmology.
Annette Beautrais, ph.d., senior 
research scientist in emergency 
medicine, and Gregory L. Larkin, 
m.d., professor of surgery 
(emergency medicine) and vice 
chair for global health and fac-
ulty development, addressed a 
conference at the United Nations 
in New York to launch World 
Suicide Prevention Day (wspd) 
on September 10. The Interna-
tional Association for Suicide 
Prevention (iasp), in conjunction 
with the World Health Organiza-
tion, sponsors wspd annually 
to highlight suicide prevention. 
Beautrais organized wspd 2009 
activities around the world in her 
role as general secretary of the 
iasp. wspd 2009 was launched 
at the UN with a press confer-
ence and a public conference 
whose theme was suicide pre-
vention in different cultures.
Henry J. Binder, m.d., professor of 
medicine (digestive diseases) and 
of cellular and molecular physiol-
ogy, has received a $1.8 million 
grant from the Gates Foundation 
to study the use of oral rehydra-
tion solutions to improve diarrhea 
control worldwide. Diarrheal dis-
ease claims the lives of between 
1.5 million and 2 million children 
every year. Oral rehydration solu-
tion (ors) reduces mortality but 
is not widely used in developing 
communities for many reasons. 
The 18-month planning grant will 
be used to examine the supply 
Annette 
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and demand for a reformulated 
ors intervention and to develop 
the framework for a four-year 
program to address the existing 
problems facing broader ors 
utilization.
Irwin M. Braverman, m.d. ’55, 
hs ’56, professor of dermatol-
ogy, was the keynote speaker at 
the Third International Medical 
Education Conference sponsored 
by Chung Shan Medical Univer-
sity in Taichung City, Taiwan, 
in July. He spoke on the use of 
“Fine Art to Enhance Observa-
tional Skills.” Braverman also 
conducted a hands-on workshop 
using reproductions of paintings 
from the Yale Center for British 
Art. During his visit to Taiwan he 
lectured as a visiting professor in 
the departments of dermatology 
at Kaohsiung Medical University 
and National Taiwan University 
School of Medicine and at a meet-
ing of the Taiwan Dermatology 
Association. 
Peter Cresswell, ph.d., a Howard 
Hughes Medical Institute inves-
tigator who has spent most of 
his career unraveling some of the 
mysteries of the human immune 
system, has been named the 
Eugene Higgins Professor of  
Immunobiology. Cresswell’s re- 
search focuses on the molecular 
mechanisms of antigen process-
ing, in which fragments of pro-
teins from viruses, bacteria, and 
other disease-causing organisms 
bind to the major histocompat-
ibility complex molecules on 
human cells during an infection.
Myron Genel, m.d., professor 
emeritus of pediatrics, recently 
completed a three-year term on 
the Health and Human Services 
(hhs) Secretary’s Advisory Com-
mittee on Human Research 
Protections, which advises the 
secretary on the responsible 
conduct of research involving 
human subjects. Genel received 
a certificate of appreciation from 
Howard K. Koh, m.d. ’77, hhs as-
sistant secretary of health.
Ami Klin, ph.d., fw ’92, a devel-
opmental psychologist and a 
world-renowned expert on severe 
developmental disorders, was 
named the Harris Professor of 
Child Psychology and Psychiatry 
in July. Klin is the director of the 
Yale Child Study Center’s Autism 
Program, which is dedicated to 
providing comprehensive clinical 
services to children with autism 
spectrum disorders and their 
families. The Yale psychologist 
has created new methods for 
studying social understanding in 
young children and in individuals 
with developmental disorders. 
His current research focuses on 
mechanisms of socialization and 
their disruption in the autism 
spectrum disorders. 
Marvin Moser, m.d., clinical pro-
fessor of medicine (cardiology), 
recently retired as editor in chief 
of The Journal of Clinical Hyper-
tension and has become editor in 
chief of The Medical Roundtable, 
Cardiovascular Edition. The new 
journal will highlight expert pan-
els on controversial topics in car-
diology. Other faculty members 
who will serve as editors include 
Lawrence S. Cohen, m.d., hs ’65, 
the Ebenezer K. Hunt Professor of 
Medicine (cardiology) Emeritus; 
John F. Setaro, m.d., hs ’86, 
fw ’92, associate professor of 
medicine (cardiology); and John 
A. Elefteriades, m.d. ’76, hs ’83, 
the William W.L. Glenn Professor 
of Surgery (cardiothoracic).
Sara C. Rockwell, ph.d., professor 
of therapeutic radiology and 
pharmacology and associate dean 
for scientific affairs, has been 
named one of 11 astro fellows 
for 2009 by the American Society 
for Radiation Oncology, the 
leading organization in radiation 
oncology, biology, and physics. 
Members of astro are eligible to 
become a fellow if they have been 
part of the society for at least 20 
years and have shown excellence 
in research, patient care, educa-
tion, leadership, and service. 
Rockwell, who joined the Yale 
faculty in 1974, was one of the 
first researchers to study the ef-
fects of hypoxia on the response 
of malignant cells in culture and 
solid tumors in vivo to radiation, 
anticancer drugs, and combined 
modality therapy.
James E. Rothman, ph.d. ’71, 
chair of the Department of Cell 
Biology and the Fergus F. Wallace 
Professor of Biomedical Sciences, 
has received a two-year $969,272 
Recovery Act grant from the 
National Institute of General 
Medical Sciences (nigms). The 
grant is part of the National 
Institutes of Health Challenge 
Grant initiative to jump-start a 
range of research projects that 
will address critical gaps in the 
basic biomedical and behavioral 
sciences by overcoming specific 
scientific and technological chal-
lenges. Rothman’s award is one 
of 19 nigms Challenge Grants 
given to researchers in 12 states. 
Rothman will investigate the 
dynamics of membrane structure 
and function in cells.
Gerald I. Shulman, m.d., ph.d., 
an internationally known dia-
betes researcher and a Howard 
Hughes Medical Institute in-
vestigator, has been named the 
first George R. Cowgill Profes-
sor of Physiological Chemistry. 
Shulman’s research is aimed 
at understanding the cellular 
mechanisms of insulin resis-
tance, the role of the liver and 
muscle in the pathogenesis of 
type 2 diabetes, and the benefits 
of exercise in the management 
of the disease. 
Stephen G. Waxman, m.d., 
ph.d., the Bridget Marie Flaherty 
Professor of Neurology, Neuro-
biology, and Pharmacology and 
director of the Yale Center for 
Neuroscience and Regeneration 
Research at the VA Connecticut 
Healthcare System, received the 
Annual Review Prize, the premier 
award of the British Physiologi-
cal Society, in July. Waxman is 
being honored for his research 
on sodium channels and their 
roles in multiple sclerosis, spinal 
cord injury, and neuropathic pain. 
Waxman delivered the Annual 
Review Prize Lecture, titled “Fire, 
Fantoms and Fugu: Sodium Chan-
nels From Squid to Clinic,” at the 
annual meeting of the Physiologi-
cal Society in Dublin, in July.
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First-year class embraces 
study of medicine
Ninety-nine new students don white 
coats in a ceremony marking the 
beginning of their medical careers.
Harkness Auditorium was aflutter with 
nervous excitement on August 25 as the 
Class of 2013—or “2014 or somewhere 
in that vicinity,” joked Dean Robert J. 
Alpern, m.d.—gathered for this year’s 
White Coat Ceremony. The 99 students 
in the class include 46 women and 
53 men, 25 graduates of Harvard and 
Yale, 19 members of ethnic or racial 
abov e  Caroline Ong smiled as she left the 
stage in her white coat.
r i ght  Laura Wang outside Sterling Hall of 
Medicine after posing for a group photo.
far r i ght  Michael Alpert received his coat 
from Laura Ment.
be l ow, t o p  Thomas Lynch, the head of Yale 
Cancer Center, urged the class to value their con-
nections to classmates, faculty, and patients.
be l ow, bo t t om  In their new white coats, the 
students left Sterling Hall of Medicine to pose for 











groups underrepresented in medicine, 
and 18 persons born outside the United 
States. The group’s average mcat score 
was 11.9 per section, the highest in the 
school’s history. The average gpa was 
3.78. “It’s an exceptionally talented and 
accomplished group,” said Richard A. 
Silverman, director of admissions.
Thomas J. Lynch Jr., m.d. ’86, who 
came to Yale from Harvard last year to 
head Yale Cancer Center and Smilow 
Cancer Hospital at Yale-New Haven, 
spoke to the new students on the theme 
of connection—connection among 
classmates, connection with faculty, 
and—“since today is your White Coat 
Ceremony,”—connection with patients. 
“Remember how profound and wonder-
ful the career you’ve chosen is,” Lynch 
said. “I’m someone who feels incred-
ibly privileged and lucky to be a doctor. 
And I think all of you will come to that, 

















Student loses long struggle  
with leukemia despite search 
for bone marrow match 
Natasha Collins, a member of the Class 
of 2012 whose classmates rallied to 
find her a bone marrow donor, died on 
August 12 at the age of 26.
Collins had been diagnosed with 
acute myelogenous leukemia about five 
years earlier and had received chemo-
therapy and a cord blood transplant. 
When the cancer returned in February, 
her classmates launched an interna-
tional search for a bone marrow donor—
an effort complicated because Collins 
was biracial.
“Great efforts were made to get 
a match,” said Mark D. Siegel, m.d., 
fw ’95, associate professor of medicine 
(pulmonary), who oversaw her care in 
her final days. Siegel spoke at a meeting 
in August to inform the medical school 
community of the circumstances of 
Collins’s passing. “Unfortunately, they 
could never get a perfect match. The 
leukemia got to the point where her  
only chance for survival was to go with  
a transplant with a slight mismatch.”
After the transplant Collins de- 
veloped a severe form of a liver syn-
drome, which led to multiple organ 
failure and her death. 
Her friends, family, classmates, and 
teachers gathered in Battell Chapel on 
September 22 to remember and honor 
her. They recalled a young woman of 
promise as well as sensitivity, honesty, 
compassion, joy, and warmth. They 
shared memories of her playing vio-
lin in the medical school orchestra; a 
homemade kale and bean soup that 
went awry; and her open and honest 
approach to her own cancer.
“I do not believe,” said one of her 
teachers, John E. Fenn, m.d., clinical 
professor of surgery, “that her illness 
enhanced the kindness that was already 
there. … Her compassion existed irre-
spective of her illness.” 
“It was one of my favorite moments 
of each day, walking in, sitting next 
to her, and seeing her smile,” said 
classmate Whitney Sheen, recalling 
attending lectures with Collins. Sheen 
accompanied herself on the guitar and 
sang a Kate Wolf song, “Across the Great 
Divide,” in Collins’ honor.
“What a great doctor she would have 
been,” said Nancy R. Angoff, m.p.h. ’81, 
m.d. ’90, hs ’93, associate dean for 
student affairs. “What better doctors 
we can each be because of her. She 
will shine on in us and make us better 
people and better doctors.”
—John Curtis
Natasha Collins, who died in August after a bone 
marrow transplant, as a first-year student in 
anatomy class with one of her teachers, Cheryl 



















s Eric Nestler created a stir when he joined the 
faculty in 1987 and put a sign on his door that 
read “Laboratory of Molecular Psychiatry.” 
Many in psychiatry, he said, took offense at the 
notion that psychiatry could be understood at 
the molecular level.
Mental illness at the 
molecular level
Eric Nestler’s molecular approach  
to psychiatric disorders set off a  
firestorm in his department.
When Eric J. Nestler, ph.d. ’82, m.d. 
’83, hs ’87, joined Yale’s Department of 
Psychiatry in 1987, he ordered a sign for 
his research space that read “Laboratory 
of Molecular Psychiatry.”
“It was like a lightning rod,” he 
recalled. “A lot of people in psychiatry 
were offended because they believed 
that you can’t understand psychiatric 
phenomena at a molecular level.”
But Nestler relished his status as 
a contrarian whose research countered 
existing beliefs.
During his 13 years on the psychia-
try faculty, where he was the Elizabeth 
Mears and House Jameson Professor 
of Psychiatry, Pharmacology, and 
Neurobiology and director of both the 
Abraham Ribicoff Research Facilities 
and the Division of Molecular Psychiatry, 
Nestler explored the molecular mecha-
nisms of drug addiction and depression 
in animal models. His focus was on how 
drugs and stress alter brain pathways in 
ways that lead to long-lasting behav-
ioral changes. “The main contribution 
that I’ve made is demonstrating a con-
vergence among the fields of molecular 
biology, neuroscience, and psychiatry,” 
said Nestler. “A molecular understanding 
of certain psychiatric phenomena is pos-
sible, as we’ve demonstrated specifically 
for addiction and depression.”
Psychiatry, said Nestler, who is now 
at the Mount Sinai School of Medicine 
in New York, has often lagged behind 
other medical areas in understand-
ing the molecular underpinnings of 
disease. This is due in large part to the 
extraordinary complexity of the brain. 
His work has helped to counteract this 
trend by using state-of-the-art molecu-
lar biology tools to define disease patho-
genesis, thereby helping to reintegrate 
psychiatry into mainstream biomedical 
science. In recognition of his accom-
plishments, Nestler was elected to the 
Institute of Medicine in 1998 and the 
American Academy of Arts and Sciences 
in 2005. He was also awarded the 
Goldman-Rakic Prize by the National 
Alliance for Research on Schizophrenia 
and Depression in 2008.
Nestler arrived at Yale as an under-
graduate in 1972, and he jokes that his 
long history at Yale made him one of 
the most Yale-degreed people around, 
“but not necessarily the wisest.” He 
came to Yale College from Long Island, 
eager to study chemistry and biology. 
Little did he know that this move would 
mark the beginning of a 27-year stretch 
at the university. While a junior at Yale 
College, a plucky Nestler convinced Paul 
Greengard, ph.d., who taught psychia-
try and pharmacology at Yale from 1968 
to 1983, to let him undertake research 
in Greengard’s laboratory for his senior 
thesis. “The opportunity to work in the  
Greengard lab was one of the most 
important milestones of my career,” 
Nestler said. He so enjoyed his research 
with Greengard, who studied cell sig-
naling mechanisms in the nervous 
system, that he continued his graduate 
work there.
For his doctoral thesis, Nestler stud-
ied the role of protein phosphorylation 
in the nervous system. “It was very 
hard work with a lot of frustrations but, 
in the end, a lot of successes. We had 
some nice papers and I felt I learned 
a lot and contributed something to 
the lab and the field.” Indeed, Nestler 
was involved in early work supporting 
the argument that phosphorylation is 
an important event in regulating cell 
function—a discovery that garnered 
Greengard the 2000 Nobel Prize in 
Physiology or Medicine. “My claim to 
fame is that my work was the first to 
show that this process could be regu-
lated by nerve impulses—electrical 
activity in the brain—and neurotrans-
mitters,” Nestler said. When it came 
time for Nestler to set up his own lab, 
he applied his study of these signaling 
mechanisms to clinical psychiatry, spe-
cifically focusing on addiction in well-
established animal models.
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A surgeon’s journey from the 
early days of chemotherapy 
and heart surgery
During his 40 years as a practicing 
surgeon, Andrew J. Graham, m.d., 
fw ’65, hs ’66, witnessed the early use 
of chemotherapy and experienced the 
profession’s evolution from a generalist 
practice to an increasingly specialized 
one. When he started out, surgeons 
were expected to cover a wide array of 
procedures and patients. “We were true 
general surgeons,” Graham said. “We 
did all the emergencies, the gunshot 
wounds, whatever came in.” Today, as 
surgery becomes more specialized and 
general surgeons become rarer, Graham 
predicts difficulty for small towns and 
cities that lack major medical centers 
and the attendant specialist surgeons. 
Through his work as an associate clini-
cal professor of surgery and as president  
of the Yale Surgical Society from its 
inception in 1994 until this year, Graham 
has encouraged a generalist’s compre-
hensive view of surgery’s mission and its 
capacity to care for patients. 
His introduction to medicine began 
with the inspiration of his future brother-
in-law, a general practitioner and former 
mash doctor in the European Theater 
during World War II, who pursued a 
solo practice in Lexington, Mass. They 
met when Graham was an officer in 
the U.S. Navy. In 1956, upon entering 
Tufts School of Medicine, Graham lived 
with his wife and infant son in an apart-
ment above the practice. He occasion-
ally accompanied his brother-in-law 
on house calls to nearby farms and 
helped perform circumcisions in the 
office on Saturdays. 
Graham was still a fourth-year medi-
cal student when he came to New Haven 
for the surgical rotation that would 
determine the course of his career.  
It was 1959, and Gustaf E. Lindskog, 
m.d., was the chief of surgery at 
Grace-New Haven Hospital. Working 
with Lindskog affirmed Graham’s 
decision to become a surgeon. “On 
the surgical rotation, if you had a 
In 2000 Nestler left Yale to become 
chair of psychiatry at the University  
of Texas Southwestern Medical Center 
at Dallas. During his tenure there, 
Nestler helped develop the psychiatry 
department’s basic and clinical research 
programs, increasing funding from 
the National Institutes of Health from 
$5 million to $20 million and recruiting 
many new faculty. At the same time, 
Nestler managed to maintain his own 
research program. 
A year ago Nestler joined Mount 
Sinai, where, as the director of the 
Mount Sinai Brain Institute, chair of the 
Department of Neuroscience, and the 
Nash Family Professor of Neuroscience, 
he plans to help build a novel transla-
tional neuroscience research program. 
The return to the Northeast has also 
allowed Nestler and his wife, Susan 
De Renzo, m.p.h. ’79, to be closer to 
their three children, ages 19, 21, and 
23, who had come back to Connecticut 
to attend college near where they grew 
up. (Nestler and De Renzo met during 
Friday afternoon happy hours at the 
medical school, and the two have been 
married for what Nestler describes as 
“28 wonderful years.”) De Renzo is a 
consultant for Hunter College and the 
City University of New York School of 
Public Health.
Looking back over his life’s accom-
plishments and his heterodox academic 
career, Nestler said, “I consider myself 
to be an extremely lucky person, both 
professionally and personally.”
—Kara A. Nyberg
problem, you solved it if you could,” 
he said. “The medical rotations were 
endless rounds of people trying to show 
how smart they were.” Lindskog invited 
Graham to stay for a subinternship and 
later, for residency. Training was rigor-
ous, with many interns working under a 
few chiefs. By the time he was chief resi-
dent himself, the attending physicians 
“would come by once a week, just to see 
what we were doing.” Otherwise, the 
residents carried their own caseloads.
In 1965, Graham was the oncologic 
fellow for section chief Mark Hayes, 
m.d., and helped administer chemo-
therapy, then still an experimental 
treatment, under the direction of Paul 
Calabresi, m.d. ’55, “We made people 
sick because we didn’t know what we 
were doing,” he said. Because oncologic 
medicine was part of general surgery at 
that time, it fell to surgeons to admin-
ister chemotherapy. And because there 
was no hospice, dying surgical cancer 
patients would find care on general 
surgical floors. Graham said, “We 
would take care of them all the way.”
After his residency, Graham went 
into solo private practice as a general 
surgeon in New Haven. A year later fel-
low surgeons and house staff alumni 
Richard A. Selzer, m.d., hs ’61, and 
Bernie S. Siegel, m.d., hs ’61, invited 
him to join their practice. Although he 
no longer performs surgeries, Graham 
remains on staff as a consulting physi-
cian. He also invites third-year Yale 
medical students to visit his practice 
for a 12-week mentorship program that 
exposes them to aspects of medicine 
often missing from a hospital rotation.  
“They find out there are a lot of little  
things that never come into the hospital,  
like a thrombosed hemorrhoid,” Graham  
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said. “Most of the residents don’t know 
what to do with that problem, since 
they’ve never seen it.” Showing the stu-
dents “the big picture of medicine”—
about caring for the whole patient in a 
surgical context—is Graham’s way of 
explaining why it is important to be a 
general surgeon. He feels that the men-
torship program run by the Department 
of Surgery is a wonderful way to bring 
“young sponges” into the field.
As president of the Yale Surgical 
Society, Graham has led the society’s 
efforts both to honor the surgical faculty 
and residents and to appeal to medi-
cal students considering surgery. This 
year, Graham stepped down from his 
15-year post. (The Surgical Society’s new 
bylaws specify that officers’ posts will 
be changed every two years.) Graham 
will remain involved with the society but 
hopes to devote more time to his wife of 
54 years, traveling, gardening, visiting 
grandchildren, and mentoring students 
alumni faces
Familiar Faces
Do you have a colleague who is making  
a difference in medicine or has followed 
an unusual path since leaving Yale? We’d 
like to hear about alumni of the School of 
Medicine; Physician Associate Program; 
and the medical school’s doctoral, fellow-
ship, and residency programs. Drop us a 
line at ymm@yale.edu or write to Faces, 
Yale Medicine, 300 George Street, Suite 
773, New Haven, CT 06511.
in his office and at the anatomy lab.  
“If someone is thinking about surgery,” 
Graham said, he tells them, “You have 
to see if you love it. … It’s a tough task-
master, and you have to be strong men-
tally and physically, because operating 
and caring for patients requires a total 
unconditional commitment. … But I’ve 
been very lucky.”
—Ayelet Amittay
When Andrew Graham became a surgeon in 
the 1960s, he was expected to do everything—
“whatever came in.” As a professor of surgery 
and as president of the Yale Surgical Society for 








spring yale service 
tour to mexico
Yale Service Tours provide a vehicle for Yale 
alumni, students, and their families to join 
in global service. Service Tours allow alumni 
to apply their diverse skills to projects in 
medical clinics, clinical home/community 
assessment and support, education, consult-
ing, sustainability programs, public works, 
arts enrichment, athletics, and more. The 
Association of Yale Alumni collaborates with 
local partners and alumni leaders to utilize 
the skills of alumni volunteers in meeting  
each community’s needs. Yale Service 
Tours programs also provide unparalleled 
opportunities to connect with people in  
the local community, learn in depth about 
the populations we serve, and form close 
bonds with fellow alumni who share a pas-
sion for service.
save the date
2010 Yale Service Tour to Monterrey, Mexico 
March 13–21, 2010 
In collaboration with Tecnológico de 
Monterrey, a private Mexican educational 






















Eliot Sorel Brian Nahed and Vanessa KerryHoward KohElizabeth 
Blackburn
Former Yale postdoc 
shares 2009 Nobel for 
research on telomeres
elizabeth h. blackburn, ph.d., 
fw ’77, sc.d.h. ’91, the Morris 
Herzstein Professor of Biology 
and Physiology at the University 
of California, San Francisco, was 
one of three American scientists 
to share the 2009 Nobel Prize in 
Physiology or Medicine “for the 
discovery of how chromosomes  
are protected by telomeres and  
the enzyme telomerase.”
Blackburn began her research 
on telomerase while she was 
a postdoctoral fellow at Yale. 
She shares the Nobel award with 
Carol W. Greider, ph.d., of Johns 
Hopkins, and Jack W. Szostak, 
ph.d., of Harvard, both of whom 
shared the Albert Lasker Basic 
Medical Research Award with her 
in 2006. 
The citation from the Nobel 
Foundation stated, “This year’s 
Nobel Prize in Physiology or Medi-
cine is awarded to three scientists 
who have solved a major problem 
in biology: how the chromosomes 
can be copied in a complete way 
during cell divisions and how they 
are protected against degradation. 
The Nobel Laureates have shown 
that the solution is to be found in 
the ends of the chromosomes—
the telomeres—and in an enzyme 
that forms them—telomerase.” 
Blackburn earned her doctorate 
from the University of Cambridge 
in England in 1975 and did her post-
doctoral work at Yale from 1975 to 
1977 in molecular and cellular biol-
ogy in the laboratory of another 
2006 Lasker honoree, Joseph G. 
Gall, ph.d. ’52. 
1950s
Robert J.T. Joy, m.d. ’54, received 
an honorary doctor of military 
medicine degree from the Uni-
formed Services University (usu) 
of the Health Sciences at their 
30th Commencement in May.  
Joy was honored for his contribu-
tions to the academic discipline  
of military medicine. Joy, who 
lives in Chevy Chase, Md., served 
in the U.S. Army from 1954 to 1981 
and was founding commander 
of the Army Research Institute of 
Environmental Medicine. He held 
senior staff positions in medical 
research in the office of the Army 
Surgeon General and in the Office 
of the Secretary of Defense.  
In 1981 he founded the Depart-
ment of Medical History at usu 
and became professor emeritus 
in 1996.
1960s
James S. Dalsimer, m.d. ’63, and 
Ellen Steinbaum, a poet and 
writer in Cambridge, Mass., were 
married on August 18 on Mount 
Desert Island, Maine. Dalsimer is 
a psychiatrist and psychoanalyst 
in private practice in Cambridge 
and a clinical instructor in 
psychiatry at Harvard Medical 
School. Steinbaum has written 
two books of poetry and until 
recently wrote a literary column 
for the Boston Globe.
1970s
Howard Koh, m.d. ’77, m.p.h., has 
been named assistant secretary 
for health at the U.S. Depart-
ment of Health and Human 
Services. The assistant secretary 
serves as the Secretary of Health 
and Human Services’ primary ad-
visor on matters involving public 
health. Koh was previously the 
Harvey V. Fineberg Professor of 
the Practice of Public Health and 
associate dean for public health 
practice at the Harvard School 
of Public Health. He also served 
as the Massachusetts Commis-
sioner of Public Health from 1997 
to 2003.
Eliot Sorel, m.d., fw ’75, was ap-
pointed a council member of the 
Woodrow Wilson International 
Center for Scholars in Washing-
ton, D.C., in June. And in October 
he was awarded an honorary 
degree by the Carol Davila Uni-
versity of Medicine and Pharmacy 
at the Romanian Athenaeum 
in Bucharest, Romania. Sorel is 
clinical professor of global health, 
health services management 
and leadership, and psychiatry 
and behavioral sciences at the 
George Washington University in 
Washington, D.C.
1990s
Samuel S. Myers, m.d. ’92, 
m.p.h., an instructor of medi-
cine at Harvard Medical School 
and research associate at the 
Harvard University Center for 
the Environment, is the author 
of Global Environmental Change: 
The Threat to Human Health, a 
report published in November by 
the Worldwatch Institute and the 
United Nations Foundation. The 
report outlines a series of public 
health threats caused by climate 
change—food and water scarcity, 
altered distribution of infectious 
diseases, increased air pollution, 
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natural disasters, and population 
displacement—that threaten 
large segments of the human 
population. The report outlines 
the need for national-level risk 
assessments to identify the great-
est threats in different regions, as 
well as unprecedented technical 
and financial assistance from the 
international community to help 
developing countries adapt to the 
health impacts of accelerating 
environmental change.
2000s
Brian V. Nahed, m.d. ’05, was 
married in October to Vanessa 
B. Kerry, m.d., in Boston. Both 
are residents at Massachusetts 
General Hospital, where they 
met in 2005. He is in his fifth year 
of a residency in neurosurgery. 
Kerry, who is in her third year of 
a residency in internal medicine, 
is a daughter of Sen. John Kerry, a 
Democrat from Massachusetts. 
Arvind Venkat, m.d. ’00, was 
promoted to associate professor 
of emergency medicine at the 
Drexel University College of Medi-
cine in Philadelphia, effective July 
1, 2009. Venkat is the director 
of research in the Department 
of Emergency Medicine and an 
ethics consultant at Allegheny 
General Hospital in Pittsburgh, 
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Lane Ameen, m.d., associate clini-
cal professor of psychiatry, died at 
his home in New Haven on June 13 
after a brief illness. He was 85.  
Ameen was also a fellow of Jona-
than Edwards College at Yale and 
medical director and ceo of a 
private psychiatric hospital. He 
came to Yale in the 1950s and 
remained for his entire career. His 
early research focused on schizo-
phrenia, psychosomatic disorders, 
and traditional psychotherapeutic 
methods of the Freudian era. He 
was later influenced by emerging 
psychopharmacological studies 
and contemporary treatments.
Ronald W. Cooke, m.d. ’43, hs ’49, 
died on August 16 in Castine, Maine. 
He was 90. After a pediatrics 
residency at Strong Memorial 
Hospital in Rochester, N.Y., Cooke 
entered the Army and served 
at Walter Reed Hospital and on 
a hospital ship. He practiced 
pediatric surgery for 30 years at 
Hartford Hospital, Newington 
Children’s Hospital, and the 
University of Connecticut Health 
Center.
Lloyd M. Felmly, m.d. ’50, died on 
September 3 in Carrollton, Ga.  
He was 89. Felmly began medical 
school at Yale in 1941 but enlisted 
in the U.S. Navy in January 1942. 
Following World War II, Felmly 
returned to medical school. He 
practiced briefly in New Jersey 
before moving to upstate New 
York, where he practiced for more 
than 40 years.
Angela R. Holder, j.d., ll.m. ’75, 
former clinical professor of 
pediatrics (law) at the School 
of Medicine, the Institution 
for Social and Policy Studies at 
Yale, and Yale Law School, died 
on April 22 at her home in Dur-
ham, N.C. She was 71. Holder’s 
research and teaching focused on 
ethical and legal issues in human 
subjects research, pediatrics, 
adolescent medicine, and human 
reproduction. Among her pub-
lications is The Meaning of the 
Constitution, a text for undergrad-
uates currently in its sixth edition. 
Holder spent her first year of law 
school as an exchange student 
at King’s College, London, and 
received her law degree from 
Tulane Law School. From 1975 to 
1977, she was executive director 
of the Program in Law, Science, 
and Medicine at Yale Law School. 
From 2001 until her retirement in 
2007, she was professor of the 
practice of medical ethics and 
humanities in the Trent Center for 
Bioethics, Humanities, and History 
of Medicine at Duke University 
Medical Center. She authored 
four books and numerous pub-
lished articles. One of the most 
meaningful honors she received, 
according to her son, John, was 
being selected by the medical 
school Class of 1988 as their Com-
mencement speaker. She also 
enjoyed impersonations of her in 
the annual second-year show.
Ruth S. Kempe, m.d. ’46, hs ’49, 
a former professor of psychiatry 
and pediatrics at the University of 
Colorado School of Medicine and 
an advocate for abused children, 
died on July 24 in Denver. She was 
87. With her husband, the late C. 
Henry Kempe, m.d., hs ’49, she 
worked at the Kempe Center for 
the Prevention and Treatment of 
Child Abuse and Neglect. Kempe 
and her husband were co-authors 
of several books, including 
Healthy Babies; Happy Parents. 
Raymond Mark, m.d. ’59, died on 
September 16 of natural causes 
at his home in Royersford, Penn. 
He was 78. After medical school, 
Mark completed a fellowship in 
pathology and immunology at 
Duke University Medical School 
and a residency in pathology 
at the University of Pittsburgh 
School of Medicine. As an immu-
nologist he was involved in the 
university’s early heart transplant 
program.
C.P. Noel McCarthy, m.d., m.p.h. 
’70, former associate clinical 
professor of obstetrics and gy-
necology, died on July 22 in New 
Haven. He was 73. McCarthy was 
an integral part of the Depart-
ment of Obstetrics, Gynecology, 
and Reproductive Sciences since 
1967. He performed his medical 
internship and residency in 
obstetrics and gynecology at the 
Hospital of St. Raphael in New 
Haven and was a fellow in infer-
tility and gynecologic infertility 
at Yale-New Haven Hospital. In 
1968 he became a clinical instruc-
tor. He later became an associate 
clinical professor, a position he 
held until his retirement in 2004. 
During that period, McCarthy 
also served as assistant chair of 
the Department of Obstetrics 
and Gynecology at the Hospital 
of St. Raphael.
Warwick Potter, m.d. ’53, died 
on August 5 of complications of 
emphysema in Wellesley, Mass. 
He was 82. After a residency at 
Children’s Hospital in Boston, 
Potter was a pediatrician in Ips-
wich, Mass., and an emergency 
room physician at Parkland 
Medical Center in Derry, N.H., 
and Marlborough Hospital in 
Massachusetts. 
Marcus E. Sanford, m.d. ’43, died 
on September 3 in Somerville, N.J. 
He was 91. During World War II 
Sanford was a captain in the Army 
Medical Corps. He was a promi-
nent physician in Somerville for 
45 years. He retired in 1991.
Julie K. Staley-Gottschalk, ph.d., 
associate professor of psychiatry 
and director of the Department 
of Psychiatry’s spect Imaging pro-
gram, died on July 25 of cancer in 
New Haven. She was 44. Staley-
Gottschalk came to Yale in 1997 
to complete a two-year postdoc-
toral fellowship in neurochemical 
brain imaging in the Department 
of Psychiatry at the VA Connecti-
cut Healthcare System in West 
Haven. Her research focused 
on the use of neuroimaging to 
understand the molecular causes 
and consequences of nicotine de-
pendence, alcoholism, depression, 
and other psychiatric disorders. 
Her contributions were recog-
nized by the Society of Biological 
Psychiatry and the Dana Clinical 

















Vivek Kulkarni, Jovana Pavisic, Vladimir Glinskii, 
and Michelle Chen played blackjack at Casino 
Night in August. The annual student-run event 
serves as an icebreaker for students and faculty, 
particularly in anatomy. By coincidence, first-
year students have their first class in anatomy 








ON THE E VE OF CL A SS,  A GA ME OF CHANCE
On the last Wednesday in August, dozens of new medical students 
tried their luck against their classmates, second-year colleagues, and 
teachers on Casino Night, held at Marigold’s. The students took 
their chances in blackjack, Texas hold ’em, and roulette—with faculty 
members as dealers and croupiers.
As it happens—and all concerned say it is a coincidence—
the new students attend their first anatomy class on the day fol-
lowing their night of gambling. That first day with a cadaver can be 
emotionally trying for students, according to anatomy faculty, who 
say it helps to meet the students beforehand in a casual setting.
“We meet them in a friendlier, more relaxed atmosphere,” 
said Lawrence J. Rizzolo, who leads the anatomy course with 
William B. Stewart.
The Medical Student Council has organized the Casino Night 
event for more than a decade. Those wishing to wager pay $5 for a 
stack of funny money that features the faces of faculty, including 
Dean Robert J. Alpern, on the bills. Faculty members like to check out 
who appears on the bills—it’s a reflection of their standing with the 
students, Rizzolo joked.
Adam Sang, a second-year student and one of the organizers 
of the event, said the evening is a welcome break from the “training 
and talking” of the orientation period. “Last year it was one of the 
most fun events for first-years.”
Among the dealers and croupiers at this year’s Casino Night 
were Alpern, as well as anatomy teachers Shanta E. Kapadia and 
Michael K. O’Brien, Auguste H. Fortin, Karen Jubanyik, and, of course, 
Stewart and Rizzolo.
—John Curtis
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